<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57381</article-id><article-id pub-id-type="doi">10.7554/eLife.57381</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-181465"><name><surname>Yoshida</surname><given-names>Saishu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2574-6410</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181466"><name><surname>Aoki</surname><given-names>Katsuhiko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181467"><name><surname>Fujiwara</surname><given-names>Ken</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181468"><name><surname>Nakakura</surname><given-names>Takashi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181470"><name><surname>Kawamura</surname><given-names>Akira</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9914-7306</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181471"><name><surname>Yamada</surname><given-names>Kohji</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181472"><name><surname>Ono</surname><given-names>Masaya</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181469"><name><surname>Yogosawa</surname><given-names>Satomi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-181172"><name><surname>Yoshida</surname><given-names>Kiyotsugu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3108-7383</contrib-id><email>kyoshida@jikei.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biochemistry, The Jikei University School of Medicine</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution>Division of Histology and Cell Biology, Department of Anatomy, Jichi Medical University School of Medicine</institution><addr-line><named-content content-type="city">Tochigi</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution>Department of Anatomy, Graduate School of Medicine, Teikyo University</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution>Department of Clinical Proteomics, National Cancer Center Research Institute</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Pedersen</surname><given-names>Lotte</given-names></name><role>Reviewing Editor</role><aff><institution>University of Copenhagen</institution><country>Denmark</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sengupta</surname><given-names>Piali</given-names></name><role>Senior Editor</role><aff><institution>Brandeis University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>06</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57381</elocation-id><history><date date-type="received" iso-8601-date="2020-03-30"><day>30</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-07-14"><day>14</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Yoshida et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Yoshida et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57381-v1.pdf"/><abstract><p>Mammalian Hedgehog (Hh) signaling plays key roles in embryogenesis and uniquely requires primary cilia. Functional analyses of several ciliogenesis-related genes led to the discovery of the developmental diseases known as ciliopathies. Hence, identification of mammalian factors that regulate ciliogenesis can provide insight into the molecular mechanisms of embryogenesis and ciliopathy. Here, we demonstrate that DYRK2 acts as a novel mammalian ciliogenesis-related protein kinase. Loss of <italic>Dyrk2</italic> in mice causes suppression of Hh signaling and results in skeletal abnormalities during in vivo embryogenesis. Deletion of <italic>Dyrk2</italic> induces abnormal ciliary morphology and trafficking of Hh pathway components. Mechanistically, transcriptome analyses demonstrate down-regulation of <italic>Aurka</italic> and other disassembly genes following <italic>Dyrk2</italic> deletion. Taken together, the present study demonstrates for the first time that DYRK2 controls ciliogenesis and is necessary for Hh signaling during mammalian development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>DYRK2</kwd><kwd>ciliogenesis</kwd><kwd>hedgehog signal</kwd><kwd>development</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>19K16781</award-id><principal-award-recipient><name><surname>Yoshida</surname><given-names>Saishu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>17H03584</award-id><principal-award-recipient><name><surname>Yoshida</surname><given-names>Kiyotsugu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>18K19484</award-id><principal-award-recipient><name><surname>Yoshida</surname><given-names>Kiyotsugu</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>16H06276 (AdAMS)</award-id><principal-award-recipient><name><surname>Yoshida</surname><given-names>Kiyotsugu</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Yoshida</surname><given-names>Saishu</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007962</institution-id><institution>the Jikei University Research Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Yoshida</surname><given-names>Saishu</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>20H03519</award-id><principal-award-recipient><name><surname>Yoshida</surname><given-names>Kiyotsugu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>DYRK2 regulator governs the mammalian ciliogenesis to maintain proper embryogenesis via activation of the Hh signaling during development in vivo.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Embryogenesis and patterning of cell differentiation are facilitated by spatiotemporal activation of multiple signaling pathways. The Hedgehog (Hh) signaling is an evolutionarily conserved system that plays a central role in embryogenesis via regulating cell proliferation and differentiation (<xref ref-type="bibr" rid="bib17">Ingham and McMahon, 2001</xref>). Upon stimulation by ligands, post-translational modification of GLI2 and GLI3 induces the expression of <italic>Gli1</italic>, which is a key amplifier of Hh signaling. These post-translational and transcriptional activations of three GLIs regulate specific and redundant target genes (<xref ref-type="bibr" rid="bib31">Mo et al., 1997</xref>; <xref ref-type="bibr" rid="bib15">Hui and Angers, 2011</xref>). Hence, mutants of Hh components cause typical defects such as skeletal, neural, and retinal abnormalities (<xref ref-type="bibr" rid="bib31">Mo et al., 1997</xref>).</p><p>Unlike other core developmental signaling, vertebrate Hh signaling is uniquely and completely dependent upon primary cilia, which are microtubule-based organelles that are formed during the G<sub>0</sub> or G<sub>1</sub> phases of the cell cycle (<xref ref-type="bibr" rid="bib14">Huangfu et al., 2003</xref>). Binding of Hh ligands to Patched 1 (PTCH1) on cilia leads to activation and induction of Seven-spanner smoothened (SMO) to the cilia (<xref ref-type="bibr" rid="bib45">Rohatgi et al., 2007</xref>). Activated SMO leads to recruitment of GLI2 and GLI3 to the cilia tip via inhibition of protein kinase A (<xref ref-type="bibr" rid="bib5">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Wen et al., 2010</xref>). This dynamic ciliary trafficking of Hh components is primarily regulated by intraflagellar transport (IFT) (<xref ref-type="bibr" rid="bib11">Haycraft et al., 2005</xref>; <xref ref-type="bibr" rid="bib7">Eguether et al., 2014</xref>). Thus, ciliogenesis is indispensable for tissue development, and defects in this process impact the development of multiple organs to cause human and mouse diseases termed ‘ciliopathies’ (<xref ref-type="bibr" rid="bib44">Reiter and Leroux, 2017</xref>). Accordingly, the typical phenotype observed in some of ciliopathies such as Joubert syndrome is abnormalities of Hh signaling (<xref ref-type="bibr" rid="bib1">Bangs and Anderson, 2017</xref>).</p><p>Mutations in a number of different ciliopathy-associated genes often result in alterations of ciliary length (<xref ref-type="bibr" rid="bib38">Paige Taylor et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Reiter and Leroux, 2017</xref>). Indeed, genetic screenings of <italic>Chlamydomonas</italic>, which is a model organism for ciliogenesis, have identified the ciliopathy-associated genes controlling cilia length to generate the optimal length at steady-state (<xref ref-type="bibr" rid="bib57">Wemmer and Marshall, 2007</xref>). Although these abnormalities in ciliary length are thought to be controlled by the balance of assembly and disassembly via IFT and a postulated length sensor, the mechanisms for maintaining the cell-type-specific ciliary length have not been fully elucidated (<xref ref-type="bibr" rid="bib19">Ishikawa and Marshall, 2011</xref>). In contrast, the ciliary resorption mechanisms for cell cycle re-entry have been thoroughly investigated by such as an experiment of serum re-addition to starved cells, and these mechanisms include the HEF1-AURKA-HDAC6 pathway (<xref ref-type="bibr" rid="bib42">Pugacheva et al., 2007</xref>), the PLK-KIF2A pathway (<xref ref-type="bibr" rid="bib55">Wang et al., 2013</xref>), and the NEK2-KIF24 pathway (<xref ref-type="bibr" rid="bib24">Kobayashi et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Kim et al., 2015b</xref>) that have been observed to induce disassembly of cilia. On the other hand, the ability of these ciliary resorption factors for cell cycle re-entry to control cilia length at steady-state and during ciliogenesis remains to be elucidated. Hence, identification of novel mammalian factors regulating ciliogenesis and ciliary length control will provide insight into the molecular mechanisms underlying embryogenesis and ciliopathy as well as ciliary functions.</p><p>Dual-specificity tyrosine-regulated kinase (DYRK) is a family that belongs to the CMGC group that includes cyclin-dependent kinases (<underline>C</underline>DK), mitogen-activated protein kinase (<underline>M</underline>APK), glycogen synthase kinase (<underline>G</underline>SK), and CDK-like kinase (<underline>C</underline>LKs) (<xref ref-type="bibr" rid="bib2">Becker and Sippl, 2011</xref>). Two isoforms of <italic>Dyrk2</italic> have been identified; long and short forms, the latter lacks a 5’ terminal region. In human cancer cells, we have functionally identified DYRK2 as a regulator of p53-induced apoptosis in response to DNA damage (<xref ref-type="bibr" rid="bib49">Taira et al., 2007</xref>) and of G1/S transition (<xref ref-type="bibr" rid="bib51">Taira et al., 2012</xref>). During development in lower eukaryotes, MBK2, which is an ortholog of DYRK2 in <italic>Caenorhabditis elegans</italic>, regulates maternal-protein degradation during the oocyte-to-embryo transition via a ubiquitin-dependent mechanism (<xref ref-type="bibr" rid="bib40">Pellettieri et al., 2003</xref>; <xref ref-type="bibr" rid="bib39">Pang et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Lu and Mains, 2007</xref>; <xref ref-type="bibr" rid="bib61">Yoshida and Yoshida, 2019</xref>). While these reports lead us to speculate that DYRK2 must also play important roles in mammalian development, no reports are available regarding the mechanistic role of DYRK2 in vivo.</p><p>In the present study, we aim to reveal a function for DYRK2 in mammalian development in vivo. Here, we demonstrate that DYRK2 is a novel regulator of ciliogenesis and is required for normal embryogenesis via activation of Hh signaling during development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Dyrk2</italic> deficiency cause suppression of Hedgehog signaling during mouse embryogenesis</title><p>We generated <italic>Dyrk2</italic> knockout mice (<italic>Dyrk2<sup>-/-</sup></italic>) by eliminating the third exon of the <italic>Dyrk2</italic> genomic locus (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B</xref>). The absence of DYRK2 protein in homozygous <italic>Dyrk2<sup>-/-</sup></italic> mice was confirmed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Although the gross morphology of homozygous <italic>Dyrk2<sup>-/-</sup></italic> embryos appeared normal during early development, multiple defects became obvious during later stages of gestation, and the mice died at or close to birth (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Specifically, defects in skeletal development were remarkable, and these included a shorter dorsum of the nose (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), cleft palate including hypoplasia of the tongue (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>), loss of the basisphenoid, basioccipital, and presphenoid bones (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), shorter limbs (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), defects of segmentation of the sternebrae in the sternum (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), and vertebra (<xref ref-type="fig" rid="fig1">Figure 1G</xref>) at embryonic day (E) 18.5. These skeletal defects that included reduction of bone mineralization were observed until E16.5 (<xref ref-type="fig" rid="fig1">Figure 1H</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Deletion of DYRK2 shows skeletal defects in mouse development.</title><p>(<bold>A</bold>) Whole embryo gross images of wild-type and homozygous <italic>Dyrk2<sup>-/-</sup></italic> embryos at birth. (<bold>B, C</bold>) Palatal and tongue abnormalities in <italic>Dyrk2<sup>-/-</sup></italic> embryos. Gross images of the palate with mandible removed from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E18.5 (<bold>B</bold>), and HE staining from the coronal plane at E13.5 (<bold>C</bold>). Dotted lines in (<bold>B</bold>) and an asterisk in (<bold>C</bold>) indicate cleft of the secondary palate. (<bold>D–H</bold>) Arizarin red and alcian blue staining of the craniofacial skeleton (<bold>D</bold>), forelimbs (<bold>E</bold>), sternum (<bold>F</bold>), and vertebra (<bold>G</bold>) from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E18.5, and whole skeleton staining at E16.5 (<bold>H</bold>). Arrowheads in (<bold>H</bold>) indicate regions that decreasing bone mineralization. bo, basioccipital bone; bs, basisphenoid; h, humerus; r, radius; p, palatal shelves; ps, presphenoid; s, scapula; st, sternebrae; t, tongue; u, ulna. Scale bars, 5 mm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Generation of <italic>Dyrk2<sup>-/-</sup></italic> mice schematic representation of the <italic>Dyrk2<sup>-/-</sup></italic> allele (<italic>Dyrk2</italic><sup>tm1b</sup>).</title><p>(<bold>A</bold>) Cre-mediated recombination was used to generate the <italic>Dyrk2<sup>-/-</sup></italic> allele (<italic>Dyrk2</italic><sup>tm1b</sup>) from the floxed allele (<italic>Dyrk2</italic><sup>tm1a</sup>). The black boxes, red arrowheads, and blue arrowheads indicate exons, <italic>loxP</italic> sites, and <italic>FRT</italic> sites, respectively. (<bold>B</bold>) PCR-confirmed mutagenesis. (<bold>C</bold>) Immunoblotting of DYRK2 in extracts from each wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryo at E13.5. L and S indicate long and short transcriptional isoforms of DYRK2, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig1-figsupp1-v1.tif"/></fig></fig-group><p>As <italic>Dyrk2<sup>-/-</sup></italic> embryos at E18.5 exhibited a similar phenotype to that observed in response to certain defects in Hh signaling (<xref ref-type="bibr" rid="bib31">Mo et al., 1997</xref>), we assessed <italic>Gli1</italic>-expression, which is an indicator of Hh signaling activation (<xref ref-type="bibr" rid="bib34">Niewiadomski and Rohatgi, 2015</xref>). In situ hybridization demonstrated that <italic>Gli1</italic>-expression was decreased in the craniofacial region in <italic>Dyrk2<sup>-/-</sup></italic> embryos at E14.5 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Protein levels of GLI1 were also decreased at E13.5 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). <italic>Ptch1</italic>-expression, which is another indicator of Hh signaling activation (<xref ref-type="bibr" rid="bib47">Snouffer et al., 2017</xref>), was also decreased in <italic>Dyrk2<sup>-/-</sup></italic> embryos at E13.5, and this was accompanied by a decrease in <italic>Gli1</italic>; however, <italic>Shh</italic>-expression remained unchanged (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). We also observed a repression of <italic>Foxf2</italic>-expression, which is a direct target gene of GLI1 (<xref ref-type="bibr" rid="bib8">Everson et al., 2017</xref>), in the craniofacial region of <italic>Dyrk2<sup>-/-</sup></italic> embryos (<xref ref-type="fig" rid="fig2">Figure 2D–E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Deletion of DYRK2 affects activation of Hh signaling in mouse development.</title><p>(<bold>A</bold>) In situ hybridization of <italic>Gli1</italic> in the craniofacial region in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos from the sagittal plane at E14.5. (<bold>B</bold>) Immunoblotting of GLI1 in extracts from the limbs of wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E13.5. GAPDH serves as a loading control. (<bold>C</bold>) qPCR of <italic>Gli1</italic>, <italic>Ptch1</italic>, and <italic>Shh</italic> in the limbs from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E13.5. (<bold>D, E</bold>) Repression of <italic>Foxf2</italic>-expression in the craniofacial region of <italic>Dyrk2<sup>-/-</sup></italic> mice. (<bold>D</bold>) In situ hybridization of <italic>Foxf2</italic> in the craniofacial region in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos from the sagittal plane at E14.5. (<bold>E</bold>) qPCR of <italic>Foxf2</italic> in the mandibular arch from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E10.5. Hypoxanthine phosphoribosyltransferase (<italic>Hprt</italic>) in (<bold>C and E</bold>) was used as an internal standard, and fold change was calculated by comparing expression levels relative to those of wild-type. Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates). The statistical significance between wild-type and <italic>Dyrk2<sup>-/-</sup></italic> was determined by the Student’s <italic>t</italic>-test. (*) p&lt;0.05, (**) p&lt;0.01. t, tongue; ul, upper lip. Scale bars, 500 µm.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2C and E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Dorsal-ventral patterning of the neural tube in <italic>Dyrk2<sup>-/-</sup></italic> mice.</title><p>(<bold>A</bold>) Transverse sections of wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E10.5 (at the branchial level) were stained for markers of ventral (FOXA2, NKX2.2, OLIG2, and NKX6.1) and dorsal (PAX6) regions. Nuclei were stained with DAPI (blue). (<bold>B</bold>) qPCR of <italic>Gli1</italic>, <italic>Ptch1</italic>, <italic>Shh</italic>, and <italic>Foxf2</italic> in the whole embryos from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E9.5. Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates). The statistical significance between wild-type and <italic>Dyrk2<sup>-/-</sup></italic> was determined by the Student’s <italic>t</italic>-test. (*) p&lt;0.05, (**) p&lt;0.01. (<bold>C</bold>) In situ hybridization of <italic>Ptch1</italic> in the neural tube (left panels) and mandibular arch (right panels) in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E10.5 from the transverse and sagittal plane, respectively. Scale bars, 50 µm.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Loss of genes required for Hh signaling often causes defects in dorsal-ventral neural tube patterning, which is regulated by the SHH morphogen (<xref ref-type="bibr" rid="bib6">Dessaud et al., 2008</xref>). Although we investigated the localization patterns of FOXA2, NKX2.2, OLIG2, NKX6.1, and PAX6 at E10.5, we did not observe obvious differences in their expression patterns (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Expression of Hh target genes was decreased in <italic>Dyrk2<sup>-/-</sup></italic> whole embryos at E9.5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In situ hybridization demonstrated that <italic>Ptch1</italic>-expression was decreased in the mandibular arch in <italic>Dyrk2<sup>-/-</sup></italic> embryos at E10.5, but remained unchanged in the neural tube (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). These data showing the maintenance of Hh signal and dorsal-ventral patterning in the neural tube might correspond to a spatiotemporal expression-pattern of <italic>Dyrk2</italic>.</p><p>Taken together, <italic>Dyrk2</italic>-deficient embryos exhibit a robust suppression of Hh signaling and possess particular skeletal abnormalities during embryogenesis.</p></sec><sec id="s2-2"><title>DYRK2 positively regulates Hh signaling</title><p>To investigate the defect in Hh signaling in <italic>Dyrk2<sup>-/-</sup></italic> mice in more detail, we analyzed primary mouse embryonic fibroblasts (MEFs) derived from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mice. First, we measured Hh signaling activity in response to stimulation with the SMO agonist SAG. In response to stimulation with SAG, <italic>Gli1</italic> and <italic>Ptch1</italic> expression was increased in wild-type mice as previously reported (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib34">Niewiadomski and Rohatgi, 2015</xref>). In contrast, in <italic>Dyrk2<sup>-/-</sup></italic> MEFs, inductions of both <italic>Gli1</italic> and <italic>Ptch1</italic> expression by SAG was drastically repressed (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with gene expression analyses, the induction of GLI1 protein by SAG stimulation was also suppressed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Immunocytostaining for GLI1 following stimulation with SAG demonstrated that the accumulation of GLI1 protein within nuclei was clearly diminished in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). To validate whether these phenotypes observed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs are due to abnormal differentiation caused by deletion of <italic>Dyrk2</italic> during early embryogenesis, we performed a transient knockdown of <italic>Dyrk2</italic> in wild-type MEFs using two independent short interfering RNAs (siRNAs). Transient knockdown of <italic>Dyrk2</italic> also demonstrated suppression of both the mRNA and protein levels of <italic>Gli1</italic> and <italic>Ptch1</italic> in response to stimulation with SAG (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Deletion of <italic>Dyrk2</italic> suppresses activation of Hh signaling in vitro.</title><p>(<bold>A</bold>) Expression of the Hh target genes <italic>Gli1</italic> and <italic>Ptch1</italic> in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG was measured by qPCR. Data are shown as relative expression to <italic>Hprt</italic>. (<bold>B</bold>) Protein levels of GLI1 and DYRK2 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG were measured by immuno-blotting. L and S indicate long and short transcriptional isoforms of DYRK2, respectively. (<bold>C</bold>) Wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG were immune-cytostained for GLI1 (red). Nuclei were stained with DAPI (blue). Scale bars, 5 µm. (<bold>D</bold>) Expression of <italic>Gli1</italic> and <italic>Ptch1</italic> in <italic>Dyrk2<sup>-/-</sup></italic> MEFs overexpressing human <italic>DYRK2</italic> or <italic>DYRK2-K251R</italic> (kinase dead) constructs via adenovirus infection was measured by qPCR. Data indicates fold induction of 100 nM SAG against vehicle after normalization to <italic>Hprt</italic>. (<bold>E, F</bold>) Immunoblotting for GLI2 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG. Protein level as fold changes of GLI2 (<bold>E</bold>) was calculated by comparing protein levels relative to those of wild-type MEFs in the absence of SAG after normalization to the GAPDH loading control in (<bold>F</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 5, 3, and 4 biological replicates per condition in A, D, and F, respectively). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (*) p&lt;0.05, (**) p&lt;0.01.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3A and D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig3-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>A transient knockdown of <italic>Dyrk2</italic> suppresses activation of Hh signaling.</title><p>(<bold>A</bold>) Expression of <italic>Gli1</italic> and <italic>Ptch1</italic> in wild-type MEFs treated with two independent si<italic>Dyrk2</italic> for 48 hr was measured by qPCR. <italic>Hprt</italic> was used as an internal standard, and fold change of <italic>Dyrk2</italic> was calculated by comparing expression levels relative to those of siControl. Data for <italic>Gli1</italic> and <italic>Ptch1</italic> indicate fold induction of 100 nM SAG against vehicle after normalization to <italic>Hprt</italic>. Data are presented as the means ± SEM (<italic>n</italic> = 5 biological replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (*) p&lt;0.05, (**) p&lt;0.01. (<bold>B</bold>) Protein levels of GLI1 and DYRK2 in wild-type MEFs treated with si<italic>Dyrk2</italic> for 48 hr in the absence or presence of 100 nM SAG were measured by immune-blotting. L and S indicate long and short transcriptional isoforms of DYRK2, respectively. (<bold>C</bold>) Schematic representation of a kinase dead human DYRK2 protein. (<bold>D</bold>) Immunoblotting for over-expressed short form of <italic>hDYRK2</italic> or <italic>DYRK2-K251R</italic> (kinase dead) via adenovirus infection in <italic>Dyrk2<sup>-/-</sup></italic> MEFs. GAPDH serves as a loading control.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Deletion of <italic>Dyrk2</italic> affects the stabilities of GLI3 Immuno-blotting for GLI3 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG.</title><p>Protein levels as fold changes of GLI3<sup>FL</sup>, and GLI3<sup>REP</sup> (<bold>A</bold>) were calculated by comparing protein levels relative to those of wild-type MEFs in the absence of SAG after normalization to the GAPDH loading control in (<bold>B</bold> and <bold>C</bold>), respectively. The ratio of GLI3<sup>REP</sup>/GLI3<sup>FL</sup> was calculated directly according to each band intensity value (<bold>D</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (*) p&lt;0.05, (**) p&lt;0.01.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B–D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig3-figsupp2-v1.tif"/></fig></fig-group><p>To validate this suppression of Hh signaling by <italic>Dyrk2-</italic>deletion, we performed a transient over-expression experiment using wild-type human <italic>DYRK2</italic> or a <italic>DYRK2-K251R</italic> construct that expresses a kinase dead mutant (<xref ref-type="bibr" rid="bib51">Taira et al., 2012</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C–D</xref>) in <italic>Dyrk2<sup>-/-</sup></italic> MEFs using adenovirus infection (<xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref>). Over-expression of the wild-type <italic>DYRK2</italic> construct restored significant induction of <italic>Gli1</italic> and <italic>Ptch1</italic> expression upon exposure to SAG (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). In sharp contrast, over-expression of the <italic>DYRK2-K251R</italic> construct in <italic>Dyrk2<sup>-/-</sup></italic> MEFs markedly diminished <italic>Gli1</italic> and <italic>Ptch1</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Additionally, over-expression of the <italic>DYRK2-K251R</italic> construct slightly increased <italic>Gli1</italic> and <italic>Ptch1</italic> expression in comparison with that of empty vector (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This kinase-independent effect might be associated with a function of DYRK2 as a scaffold protein (<xref ref-type="bibr" rid="bib27">Maddika and Chen, 2009</xref>). Taken together, the induction of Hh signaling is drastically suppressed by deletion of <italic>Dyrk2</italic> in a kinase activity-dependent manner.</p><p>The key Hh pathway components GLI2 and GLI3 are known to be posttranslationally modified in a manner that is dependent upon Hh ligands (<xref ref-type="bibr" rid="bib31">Mo et al., 1997</xref>; <xref ref-type="bibr" rid="bib15">Hui and Angers, 2011</xref>). In the absence of Hh ligands, the full-length proteins (active forms; GLI2 and GLI3<sup>FL</sup>) are phosphorylated by multiple kinases, leading to proteasomal degradation or truncation into N-terminal repressor forms (GLI3<sup>REP</sup>), respectively (<xref ref-type="bibr" rid="bib34">Niewiadomski and Rohatgi, 2015</xref>). In this context, we analyzed the endogenous protein levels and states of GLI2 and GLI3. In wild-type MEFs, immunoblotting for GLI2 revealed that full-length form of GLI2 was increased by SAG-stimulation (<xref ref-type="fig" rid="fig3">Figure 3E–F</xref>). In contrast to wild-type MEFs, the increase of GLI2 protein levels by SAG was significantly suppressed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig3">Figure 3E–F</xref>). We also analyzed two forms of GLI3 (GLI3<sup>FL</sup> and GLI3<sup>REP</sup>). SAG-stimulation suppressed the formation of GLI3<sup>REP</sup> and decreased the ratio of GLI3<sup>REP</sup>/GLI3<sup>FL</sup> in wild-type MEFs (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; <xref ref-type="bibr" rid="bib34">Niewiadomski and Rohatgi, 2015</xref>). In <italic>Dyrk2<sup>-/-</sup></italic> MEFs, however, we found that the ratio of GLI3<sup>REP</sup>/GLI3<sup>FL</sup> was marginally suppressed and that no significant differences between the absence or presence of SAG existed (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>). Collectively, these data indicate that the deletion of <italic>Dyrk2</italic> affects the stabilities of GLI2, and marginally GLI3, under SAG-stimulation.</p></sec><sec id="s2-3"><title>DYRK2 regulates ciliogenesis</title><p>As primary cilia are essential organelles required for signal transduction of vertebrate Hh signaling (<xref ref-type="bibr" rid="bib14">Huangfu et al., 2003</xref>), we investigated whether DYRK2 regulates ciliogenesis in MEFs. Immunostaining of acetylated tubulin (a cilia axoneme marker) and γ-tubulin (a basal body marker) demonstrated that the length of primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs was significantly longer than that in wild-type MEFs (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The average cilia length in wild-type MEFs was 1.65 ± 0.03, while it was 3.59 ± 0.08 in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>). In addition to the increased length, the morphology of primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs was often bulged at the tips, tapered, and twisted (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This elongation and morphological abnormality of primary cilia was similarly observed in response to the transient knockdown of <italic>Dyrk2</italic> by siRNA in wild-type MEFs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). To investigate whether the regulation of ciliogenesis by DYRK2 is conserved in other species and cell types, we analyzed immortalized human retinal pigment epithelia cells (hTERT-RPE1 cells) that are commonly used to study cilia-assembly and -disassembly. A transient knockdown by si<italic>DYRK2</italic> also induced a significant elongation and morphological abnormality in cilia of these cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). In contrast to the length and morphology of primary cilia, no difference was observed on the proportion of ciliated cells in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–B</xref>). Similarly, in cell-cycling (KI67-positive) wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs, there was comparable in the proportion of ciliated cells (ciliated cells in KI67-positive cells is 1 per 199 and 1 per 139 cells in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs, respectively) (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>DYRK2 constrains the length of primary cilia.</title><p>(<bold>A–C</bold>) Elongation of primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs. Primary cilia of wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs were immunostained with acetylated-tubulin and gamma-tubulin antibodies. (<bold>B, C</bold>) Measurements of cilia length in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs using acetylated-tubulin as a cilia axoneme marker. Cilia lengths are presented as pooled from five MEFs derived from independent embryos of each genotype (<bold>B</bold>) and the average of each MEF (<bold>C</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 5 biological replicates per condition). The statistical significance between wild-type and <italic>Dyrk2<sup>-/-</sup></italic> was determined by the Student’s <italic>t</italic>-test. (**) p&lt;0.01. (<bold>D</bold>) Scanning electron microscopy showing wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos in the frontonasal prominence at E10.5. (<bold>E</bold>) Immunohistochemistry of primary cilia in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos. ARL13B was immuno-stained in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mesenchymal cells at the craniofacial region at E13.5. Nuclei were stained with DAPI. Scale bars, 5 µm (<bold>A and E</bold>) and 1 µm (<bold>D</bold>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4B–C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Elongation of primary cilia in wild-type MEFs treated with si<italic>Dyrk2.</italic></title><p>(<bold>A</bold>) Primary cilia of wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs treated with siControl or two independent si<italic>Dyrk2</italic> were immunostained with acetylated-tubulin and gamma-tubulin antibodies. Scale bars, 5 µm. (<bold>B, C</bold>) Measurements of cilia length in wild-type MEFs treated with siControl or si<italic>Dyrk2</italic> using acetylated-tubulin as a cilia axoneme marker. Cilia lengths are presented as pooled from three MEFs derived from independent wild-type embryos (<bold>B</bold>) and represent the average of each MEF (<bold>C</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (*) p&lt;0.05, (**) p&lt;0.01.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Elongation of primary cilia in hTERT-RPE1 cells treated with si<italic>DYRK2</italic>.</title><p>(<bold>A</bold>) Knockdown efficiency of <italic>DYRK2</italic>-expression in hTERT-RPE1 cells treated with two independent si<italic>DYRK2</italic> for 48 hr was measured by qPCR. <italic>HPRT1</italic> was used as an internal standard, and fold change was calculated by comparing expression levels relative to those of siControl. (<bold>B</bold>) Primary cilia of hTERT-RPE1 cells treated with siControl or si<italic>DYRK2</italic> were immunostained with acetylated-tubulin and gamma-tubulin antibodies. (<bold>C, D</bold>) Measurements of cilia length in hTERT-RPE1 cells treated with siControl or two independent si<italic>DYRK2</italic> using acetylated-tubulin as a cilia axoneme marker. Scale bars, 5 µm. Cilia lengths are presented as pooled from three independent experiments (<bold>C</bold>) and represent the average of each condition (<bold>D</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (**) p&lt;0.01.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and C–D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig4-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Quantification of the proportion of ciliated cells in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</title><p>(<bold>A, B</bold>) Proportion of ciliated cells in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs. Primary cilia of wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs were immunostained with ARL13B (<bold>A</bold>). Measurements of proportion of ciliated cells in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs using ARL13B as a cilia axoneme marker (<bold>B</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition;&gt;150 cells were scored for each experiment). The statistical significance between wild-type and <italic>Dyrk2<sup>-/-</sup></italic> was determined by the Student’s <italic>t</italic>-test. (<bold>C</bold>) Proportion of ciliated cells in cell-cycling wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs. Wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs cultured under 10% FBS containing medium at low density were immunostained with KI67 and ARL13B. Nuclei were stained with DAPI. Arrowheads and arrows indicate non-ciliated/KI67-positive cycling cells and ciliated/KI67-negative ones, respectively. Scale bars, 50 µm.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig4-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig4-figsupp3-v1.tif"/></fig></fig-group><p>To confirm the morphological abnormalities of primary cilia within the tissue, we performed scanning electron microscopy (SEM) on embryos at E10.5. SEM images clearly showed that the cilia of <italic>Dyrk2<sup>-/-</sup></italic> embryos were significantly elongated, bulged at the tips, and twisted, while those of wild-type embryos were shortened and straight (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These abnormalities were also observed in several types of cells, including mesenchymal cells (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), chondrocytes, neuroepithelium, and tongue cells (data not shown) in the embryonic craniofacial region at E13.5 as assessed by immunohistochemistry.</p><p>These data indicating that deletion of <italic>Dyrk2</italic> causes morphological abnormalities in primary cilia prompted us to determine the subcellular localization of DYRK2. We transfected DYRK2-HaloTag constructs into hTERT-RPE1 cells and induced ciliogenesis by serum-starvation. Immunocytostaining for both anti-HaloTag and anti-DYRK2 revealed that DYRK2 localized at γ-tubulin-positive basal bodies and at the proximal end of the axoneme, namely a transition zone (TZ) (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). No signal for anti-HaloTag (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) or anti-DYRK2 (data not shown) was observed in hTERT-RPE1 cells transfected with empty vector (pFN22K-Halo Tag-CMVd1-Flexi-vector). Moreover, immuno-positive signals for DYRK2-HaloTag were co-localized with a TZ marker, NPHP1 (<xref ref-type="fig" rid="fig5">Figure 5D</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>DYRK2 localizes at basal bodies and transition zone (TZ) in primary cilia.</title><p>Cultured hTERT-RPE1 cells were transfected with a mouse DYRK2-HaloTag overexpression construct and immunostained using anti-HaloTag (<bold>A</bold>) or anti-DYRK2 (<bold>B</bold>) with acetylated-tubulin (white) and gamma-tubulin antibodies. (<bold>C</bold>) Cultured hTERT-RPE1 cells transfected with an empty vector (pFN22K-Halo Tag-CMVd1-Flexi-vector) and immunostained using anti-HaloTag with acetylated-tubulin (white) and gamma-tubulin antibodies. (<bold>D</bold>) Co-localization of DYRK2 and a TZ marker, NPHP1. Cultured hTERT-RPE1 cells overexpressed with a mouse DYRK2-HaloTag were immunostained using anti-HaloTag, NPHP1 (white), and gamma-tubulin antibodies. Nuclei were stained with DAPI. Scale bars, 5 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig5-v1.tif"/></fig><p>These data indicated that DYRK2 might regulate ciliogenesis at basal bodies and TZ in vivo and in vitro.</p></sec><sec id="s2-4"><title>Deletion of DYRK2 induces abnormal ciliary trafficking of Hedgehog pathway components</title><p>In mammals, key regulators of Hh signaling have been demonstrated to be recruited and activated at the cilia upon Hh stimulation (<xref ref-type="bibr" rid="bib5">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Tukachinsky et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Wen et al., 2010</xref>), and disorders in the ciliary trafficking of Hh components cause dysfunction of Hh signaling (<xref ref-type="bibr" rid="bib12">He et al., 2014</xref>). To investigate whether inactivation of Hh signaling in <italic>Dyrk2<sup>-/-</sup></italic> embryos and MEFs is due to abnormal ciliary trafficking of Hh components, we analyzed the ciliary localization of key regulators such as SMO, GLI2, GLI3, and SuFu. In wild-type MEFs, immuno-positive SMO signals were mostly undetectable or faint in the absence of Hh stimulation, and recruitment to cilia was dependent upon Hh stimulation (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>), as shown in a previous report (<xref ref-type="bibr" rid="bib53">Tukachinsky et al., 2010</xref>). Similarly, no significant difference in the frequency of SMO recruitment in response to SAG stimulation was observed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Depletion of <italic>Dyrk2</italic> induces abnormal ciliary trafficking of endogenous Hh components.</title><p>Ciliary localization of endogenous SMO, GLI2, and GLI3 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG. Primary cilia were immuno-stained for SMO (<bold>A</bold>), GLI2 (<bold>C</bold>), or GLI3 (<bold>E</bold>) with ARL13B and gamma-tubulin (white) antibodies. Nuclei were stained with DAPI (blue). The percentage of cells with SMO (<bold>B</bold>) at the cilia or foci of GLI2 (<bold>D</bold>) or GLI3 (<bold>F</bold>) at the cilia tips was determined. Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates for each condition;&gt;110 cells were scored for each experiment). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (*) p&lt;0.05, (**) p&lt;0.01. Scale bars, 5 µm.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6B,D and F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Depletion of <italic>Dyrk2</italic> induces abnormal ciliary trafficking of endogenous GLI2 and GLI3 in vivo.</title><p>Immunohistochemistry for GLI2 and GLI3 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mesenchymal cells in the craniofacial region at E10.5 tissues. Primary cilia were immuno-stained for GLI2 (<bold>A</bold>) or GLI3 (<bold>B</bold>) with ARL13B and gamma-tubulin (white) antibodies. Nuclei were stained with DAPI (blue). Scale bars, 5 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Immunocytochemistry of endogenous SuFu and IFTs.</title><p>(<bold>A</bold>) Ciliary localization of endogenous SuFu in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG. Primary cilia were immunostained for SuFu with ARL13B and gamma-tubulin (white) antibodies. (<bold>B–D</bold>) Ciliary localization of endogenous IFTs in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs. Primary cilia were immuno-stained for IFT140 (<bold>B</bold>), IFT81 (<bold>C</bold>), or IFT88 (<bold>D</bold>) with acetylated-tubulin and gamma-tubulin (white) antibodies. Nuclei were stained with DAPI (blue). Scale bars, 5 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Effects of rapamycin treatment on cilia.</title><p>(<bold>A</bold>) Phosphorylated protein levels of S6K and 4EBP in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs were measured by immunoblotting. GAPDH serves as a loading control. (<bold>B</bold>) Primary cilia in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs treated with vehicle (DMSO) or 0.5 µM rapamycin for 24 hr were immunostained with acetylated-tubulin (red) and gamma-tubulin (green) antibodies. Nuclei were stained with DAPI (blue). Scale bars, 5 µm. (<bold>C, D</bold>) Measurements of cilia length in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs treated with vehicle (DMSO) or 0.5 µM rapamycin using acetylated-tubulin as a cilia axoneme marker. Cilia lengths are presented as pooled from three MEFs derived from independent embryos of each genotype (<bold>C</bold>) and the average of each MEF (<bold>D</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test.</p><p><supplementary-material id="fig6s3sdata1"><label>Figure 6—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3C–D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig6-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Protein levels of CP110 and KATANIN p60 in <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</title><p>Protein levels of CP110 and KATANIN p60 in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> were measured by immune-blotting. GAPDH serves as a loading control.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig6-figsupp4-v1.tif"/></fig></fig-group><p>We subsequently analyzed the ciliary localization of endogenous GLI2 and GLI3. As shown in a previous report (<xref ref-type="bibr" rid="bib53">Tukachinsky et al., 2010</xref>), in wild-type MEFs, immuno-positive signals for both GLI2 and GLI3 were mostly undetectable or faint in the absence of Hh stimulation, and SAG stimulation increased the presence of GLI2 and GLI3 at cilia tips (<xref ref-type="fig" rid="fig6">Figure 6C–F</xref>). In contrast, in <italic>Dyrk2<sup>-/-</sup></italic> MEFs, immuno-positive signals for both GLI2 (approximately 75.9% of cilia) and GLI3 (approximately 95.8%) were observed at cilia tip even in the absence of SAG treatment (<xref ref-type="fig" rid="fig6">Figure 6C–F</xref>). Moreover, the intensity of immune-positive signals was markedly increased by SAG-treatment in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig6">Figure 6C,E</xref>). These accumulations at cilia tips were frequently observed in <italic>Dyrk2<sup>-/-</sup></italic> mesenchymal cells in the craniofacial region at E10.5 tissues but were absent in wild-type cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Additionally, localization of SuFu, which forms a complex with both GLI2 and GLI3 (<xref ref-type="bibr" rid="bib53">Tukachinsky et al., 2010</xref>), was disordered in cilia tips in a similar pattern to that of GLI2 and GLI3 (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). Collectively, ciliary localization of GLI2, GLI3, and SuFu in <italic>Dyrk2<sup>-/-</sup></italic> MEFs and embryos was clearly disordered and was accumulated at cilia tips. Importantly, the recruitment of GLI2, GLI3, and SuFu in response to SAG stimulation was also observed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</p><p>Inhibition of retrograde transport from the tip to the cell body induces accumulation of Hh components and results in abnormal localization of both IFT-A (implicated in retrograde IFT) and IFT-B (implicated in anterograde) (<xref ref-type="bibr" rid="bib37">Ocbina and Anderson, 2008</xref>; <xref ref-type="bibr" rid="bib36">Ocbina et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Liem et al., 2012</xref>). Based on this, we analyzed the ciliary localization of core IFT-A (IFT140) and IFT-B (IFT81 and IFT88) (<xref ref-type="bibr" rid="bib33">Nakayama and Katoh, 2018</xref>). In <italic>Dyrk2<sup>-/-</sup></italic> MEFs, no obvious differences in ciliary localization of IFT140, IFT81, and IFT88 were observed (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B–D</xref>).</p><p>Activation of mammalian target of rapamycin complex 1 (mTORC1) also induces abnormal trafficking and elongates cilia length (<xref ref-type="bibr" rid="bib4">Broekhuis et al., 2014</xref>). mTORC1 activation leads to phosphorylation of ribosomal S6 kinase (S6K) and eukaryotic translational initiation factor 4E binding protein (4EBP). In <italic>Dyrk2<sup>-/-</sup></italic> MEFs, phosphorylation of both S6K and 4EBP was slightly increased (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A</xref>); however, treatment with rapamycin, an inhibitor of mTORC1, resulted in no obvious differences in cilia length in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3B–D</xref>).</p><p>Moreover, a centrosome protein CP110 (<xref ref-type="bibr" rid="bib13">Hossain et al., 2017</xref>) and a microtubule severing enzyme, KATANIN p60 (<xref ref-type="bibr" rid="bib27">Maddika and Chen, 2009</xref>), have been identified as substrates of DYRK2 for proteolysis. In <italic>Dyrk2<sup>-/-</sup></italic> MEFs, however, no obvious difference in protein levels of both CP110 and KATANIN p60 was observed (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>).</p></sec><sec id="s2-5"><title>Deletion of <italic>Dyrk2</italic> dysregulates the expression of <italic>Aurka</italic> and other cilia-disassembly genes</title><p>To understand the molecular mechanisms underlying cilia dysfunction in <italic>Dyrk2<sup>-/-</sup></italic> mice, we focused on factors that are involved in ciliary length control by incorporating whole-genome RNA sequencing using wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig7">Figure 7</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). The data were analyzed by multiple testing and according to p-value, false discovery rate (FDR), and ratio (<italic>Dyrk2<sup>-/-</sup></italic>/wild-type). As a result, the number of identified genes was 53 or 42 that were significantly downregulated (p&lt;0.005, ratio &lt;1.5 fold) or upregulated (p&lt;0.005, ratio &gt;1.5 fold) in <italic>Dyrk2<sup>-/-</sup></italic> MEFs, respectively, regardless of the presence or absence of SAG (<xref ref-type="table" rid="table1">Table 1</xref>). Notably, GO and STRING analysis revealed that the 53 downregulated genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs were enriched in cell division (GO: 0051301, FDR = 5.17E-40), microtubule cytoskeleton organization (GO:0000226, FDR = 5.23E-15), spindle organization (GO:0007051, FDR = 2.72E-11), mitotic cell cycle checkpoint (GO:0007093, FDR = 3.78E-07), and microtubule-based movement (GO:0007018, FDR = 3.9E-4) (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). These downregulated genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs included those related to ciliary resorption mechanisms for proliferation, including the HEF1-AURKA-HDAC6 pathway (<italic>Aurka</italic>, <italic>Plk1</italic>, <italic>Ube2c</italic>, and <italic>Tpx2</italic>) (<xref ref-type="bibr" rid="bib42">Pugacheva et al., 2007</xref>), the PLK-KIF2A pathway (<italic>Plk1</italic> and <italic>Kif2c</italic>, a family of <italic>Kif2a</italic>) (<xref ref-type="bibr" rid="bib55">Wang et al., 2013</xref>), and the APC<sup>CDC20</sup>-Nek1 pathway (<italic>Cdc20</italic>) that controls ciliary length (<xref ref-type="bibr" rid="bib56">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Keeling et al., 2016</xref>). We confirmed the downregulation of <italic>Aurka</italic>, <italic>Plk1</italic>, <italic>Ube2c</italic>, <italic>Tpx2, Kif2c,</italic> and <italic>Cdc20</italic> in <italic>Dyrk2<sup>-/-</sup></italic> MEFs by qPCR (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). To identify a molecule involved in cilia-elongation in <italic>Dyrk2<sup>-/-</sup></italic> cells, we performed transient knockdown of selected genes using siRNA in wild-type MEFs, and we analyzed cilia length. Notably, we found that knockdown of <italic>Aurka</italic> by two independent siRNAs significantly increases cilia length (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Moreover, we performed a rescue experiment by over-expression of AURKA-EGFP in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Immunostaining and measurement of the cilia length in EGFP- (transfected with pEGFP-C1) or AURKA-EGFP-positive (transfected with <italic>Aurka</italic>/pEGFP-C1) <italic>Dyrk2<sup>-/-</sup></italic> MEFs demonstrated that elongated cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs were significantly shortened in AURKA-EGFP-positive cells in comparison with EGFP-positive ones (<xref ref-type="fig" rid="fig9">Figure 9D–G</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Changes in mRNA expression of genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</title><p>(<bold>A</bold>) STRING GO analyses of the 53 differentially downregulated genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs reveals protein-protein interaction networks. Robust networks for cell division (green, GO: 0051301), microtubule cytoskeleton organization (red, GO:0000226), spindle organization (yellow, GO:0007051), mitotic cell cycle checkpoint function (purple, GO:0007093), and microtubule-based movement (blue, GO:0007018) were extracted. (<bold>B</bold>) Confirmation of downregulation of genes related to ciliary resorption mechanisms in <italic>Dyrk2<sup>-/-</sup></italic> MEFs by qPCR. <italic>Hprt</italic> was used as an internal standard, and fold change was calculated by comparing expression levels relative to those of wild-type. Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). The statistical significance between wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs was determined using the Student’s <italic>t</italic>-test. (*) p&lt;0.05.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Transcriptome analysis in <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</title><p>(<bold>A</bold>) Venn diagrams revealing the similarities and differences among genes that were differentially expressed more than 1.5-fold from RNA-seq experiments in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs in the absence or presence of 100 nM SAG. (<bold>B</bold>) Significantly enriched gene ontology terms belonging to ‘biological process’ (false discovery rate: FDR &lt; 0.005) among 53 differentially downregulated genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig7-figsupp1-v1.tif"/></fig></fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Elongation of primary cilia in wild-type MEFs treated with si<italic>Aurka.</italic></title><p>(<bold>A</bold>) Immunoblotting of AURKA in wild-type and <italic>Dyrk2<sup>-/-</sup></italic> MEFs. GAPDH serves as a loading control. (<bold>B</bold>) Knockdown efficiency of <italic>Aurka</italic>-expression in wild-type MEFs treated with two independent si<italic>Aurka</italic> for 48 hr was measured by qPCR. <italic>Hprt</italic> was used as an internal standard, and fold change was calculated by comparing expression levels relative to those of siNegative (siNeg.). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). (<bold>C</bold>) Primary cilia in wild-type cells treated with siNegative (siNeg.) or two independent si<italic>Aurka</italic> were immuno-stained with ARL13B and gamma-tubulin antibodies. Scale bars, 5 µm. (<bold>D, E</bold>) Measurements of cilia length in wild-type MEFs treated with siNeg. or two independent si<italic>Aurka</italic> using ARL13B and acetylated-tubulin as a cilia axoneme marker. Cilia lengths are presented as pooled from four MEFs derived from independent wild-type embryos (<bold>D</bold>) and represent an average of each MEF (<bold>E</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 4 biological replicates per condition). The statistical significance was determined by one-way ANOVA followed by Tukey’s multiple comparison test. (**) p&lt;0.01.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8B and D–E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig8-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig8-v1.tif"/></fig><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Reduction of the length of primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs by over-expression of AURKA.</title><p>(<bold>A–C</bold>) Immunoblotting by anti-AURKA (<bold>A</bold>), anti-GFP (<bold>B</bold>), and anti-GAPDH (<bold>C</bold>) in cells transfected with pEGFP-C1 or mouse <italic>Aurka</italic>/pEGFP-C1. GAPDH serves as a loading control. (<bold>D, E</bold>) Primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs over-expressed with EGFP (<bold>D</bold>) or AURKA-EGFP (<bold>E</bold>) were immunostained with GFP, ARL13B, and gamma-tubulin (white) antibodies. Arrowheads in (<bold>E</bold>) indicate signals for AURKA-EGFP in gamma-tubulin-positive basal body. Scale bars, 5 µm. (<bold>F, G</bold>) Measurements of cilia length in EGFP- or AURKA-EGFP-over-expressed <italic>Dyrk2<sup>-/-</sup></italic> MEFs using ARL13B as a cilia axoneme marker. Cilia lengths in EGFP- or AURKA-EGFP-positive cells are presented as pooled from three MEFs derived from independent <italic>Dyrk2<sup>-/-</sup></italic> embryos (<bold>F</bold>) and represent an average of each MEF (<bold>G</bold>). Data are presented as the means ± SEM (<italic>n</italic> = 3 biological replicates per condition). The statistical significance between EGFP- and AURKA-EGFP-positive cells was determined by the Student’s <italic>t</italic>-test. (**) p&lt;0.01.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig9">Figure 9F and G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57381-fig9-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig9-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>A list of downregulated or upregulated genes in Dyrk2<sup>-/-</sup> MEFs</title></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="5">Down-regulated genes in Dyrk2<sup>-/-</sup></th></tr><tr><th>ID</th><th>GeneSymbol</th><th>Description</th><th>Ratio of Dyrk2<sup>-/-</sup>per wild-type in the presence of SAG</th><th>Ratio of Dyrk2<sup>-/-</sup>per wild-type in the absence of SAG</th></tr><tr><td>ENSMUSG00000028630</td><td>Dyrk2</td><td>Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2</td><td>0.02</td><td>0.03</td></tr><tr><td>ENSMUSG00000035683</td><td>Melk</td><td>Maternal embryonic leucine zipper kinase</td><td>0.23</td><td>0.22</td></tr><tr><td>ENSMUSG00000074476</td><td>Spc24</td><td>NDC80 kinetochore complex component%2C homolog (<italic>S. cerevisiae</italic>)</td><td>0.25</td><td>0.21</td></tr><tr><td>ENSMUSG00000020808</td><td>Pimreg</td><td>PICALM interacting mitotic regulator</td><td>0.28</td><td>0.28</td></tr><tr><td>ENSMUSG00000033952</td><td>Aspm</td><td>Abnormal spindle microtubule assembly</td><td>0.31</td><td>0.25</td></tr><tr><td>ENSMUSG00000026683</td><td>Nuf2</td><td>NDC80 kinetochore complex component</td><td>0.31</td><td>0.30</td></tr><tr><td>ENSMUSG00000037466</td><td>Tedc1</td><td>Tubulin epsilon and delta complex 1</td><td>0.31</td><td>0.26</td></tr><tr><td>ENSMUSG00000030867</td><td>Plk1</td><td>Polo-like kinase 1</td><td>0.31</td><td>0.17</td></tr><tr><td>ENSMUSG00000022033</td><td>Pbk</td><td>PDZ binding kinase</td><td>0.33</td><td>0.29</td></tr><tr><td>ENSMUSG00000027326</td><td>Knl1</td><td>Kinetochore scaffold 1</td><td>0.33</td><td>0.20</td></tr><tr><td>ENSMUSG00000041431</td><td>Ccnb1</td><td>Cyclin B1</td><td>0.33</td><td>0.26</td></tr><tr><td>ENSMUSG00000036777</td><td>Anln</td><td>Anillin actin binding protein</td><td>0.33</td><td>0.26</td></tr><tr><td>ENSMUSG00000001403</td><td>Ube2c</td><td>Ubiquitin-conjugating enzyme E2C</td><td>0.33</td><td>0.25</td></tr><tr><td>ENSMUSG00000027496</td><td>Aurka</td><td>Aurora kinase A</td><td>0.34</td><td>0.26</td></tr><tr><td>ENSMUSG00000001349</td><td>Cnn1</td><td>Calponin 1</td><td>0.34</td><td>0.31</td></tr><tr><td>ENSMUSG00000032218</td><td>Ccnb2</td><td>Cyclin B2</td><td>0.34</td><td>0.28</td></tr><tr><td>ENSMUSG00000026039</td><td>Sgo2a</td><td>Shugoshin 2A</td><td>0.34</td><td>0.25</td></tr><tr><td>ENSMUSG00000015880</td><td>Ncapg</td><td>Non-SMC condensin I complex subunit G</td><td>0.34</td><td>0.34</td></tr><tr><td>ENSMUSG00000027379</td><td>Bub1</td><td>BUB1 mitotic checkpoint serine/threonine kinase</td><td>0.36</td><td>0.23</td></tr><tr><td>ENSMUSG00000040084</td><td>Bub1b</td><td>BUB1B mitotic checkpoint serine/threonine kinase</td><td>0.36</td><td>0.29</td></tr><tr><td>ENSMUSG00000045328</td><td>Cenpe</td><td>Centromere protein E</td><td>0.36</td><td>0.22</td></tr><tr><td>ENSMUSG00000032254</td><td>Kif23</td><td>Kinesin family member 23</td><td>0.37</td><td>0.25</td></tr><tr><td>ENSMUSG00000028873</td><td>Cdca8</td><td>Cell division cycle associated 8</td><td>0.37</td><td>0.30</td></tr><tr><td>ENSMUSG00000032135</td><td>Mcam</td><td>Melanoma cell adhesion molecule</td><td>0.37</td><td>0.29</td></tr><tr><td>ENSMUSG00000027469</td><td>Tpx2</td><td>TPX2microtubule-associated</td><td>0.37</td><td>0.33</td></tr><tr><td>ENSMUSG00000028678</td><td>Kif2c</td><td>Kinesin family member 2C</td><td>0.37</td><td>0.24</td></tr><tr><td>ENSMUSG00000027715</td><td>Ccna2</td><td>Cyclin A2</td><td>0.38</td><td>0.23</td></tr><tr><td>ENSMUSG00000048327</td><td>Ckap2l</td><td>Cytoskeleton associated protein 2-like</td><td>0.39</td><td>0.23</td></tr><tr><td>ENSMUSG00000040204</td><td>Pclaf</td><td>PCNA clamp associated factor</td><td>0.40</td><td>0.19</td></tr><tr><td>ENSMUSG00000029414</td><td>Kntc1</td><td>Kinetochore associated 1</td><td>0.42</td><td>0.24</td></tr><tr><td>ENSMUSG00000034311</td><td>Kif4</td><td>Kinesin family member 4</td><td>0.42</td><td>0.24</td></tr><tr><td>ENSMUSG00000031004</td><td>Mki67</td><td>Antigen identified by monoclonal antibody Ki 67</td><td>0.42</td><td>0.21</td></tr><tr><td>ENSMUSG00000020914</td><td>Top2a</td><td>Topoisomerase (DNA) II alpha</td><td>0.42</td><td>0.21</td></tr><tr><td>ENSMUSG00000033031</td><td>Cip2a</td><td>Cell proliferation regulating inhibitor of protein phosphatase 2A</td><td>0.42</td><td>0.32</td></tr><tr><td>ENSMUSG00000035783</td><td>Acta2</td><td>Actin alpha two smooth muscle aorta</td><td>0.43</td><td>0.48</td></tr><tr><td>ENSMUSG00000024795</td><td>Kif20b</td><td>Kinesin family member 20B</td><td>0.43</td><td>0.30</td></tr><tr><td>ENSMUSG00000038943</td><td>Prc1</td><td>Protein regulator of cytokinesis 1</td><td>0.43</td><td>0.26</td></tr><tr><td>ENSMUSG00000026494</td><td>Kif26b</td><td>Kinesin family member 26B</td><td>0.43</td><td>0.25</td></tr><tr><td>ENSMUSG00000023015</td><td>Racgap1</td><td>Rac GTPase-activating protein 1</td><td>0.43</td><td>0.26</td></tr><tr><td>ENSMUSG00000026605</td><td>Cenpf</td><td>Centromere protein F</td><td>0.44</td><td>0.25</td></tr><tr><td>ENSMUSG00000027306</td><td>Nusap1</td><td>Nucleolar and spindle associated protein 1</td><td>0.45</td><td>0.28</td></tr><tr><td>ENSMUSG00000028068</td><td>Iqgap3</td><td>IQ motif containing GTPase activating protein 3</td><td>0.46</td><td>0.21</td></tr><tr><td>ENSMUSG00000003779</td><td>Kif20a</td><td>Kinesin family member 20A</td><td>0.47</td><td>0.25</td></tr><tr><td>ENSMUSG00000005410</td><td>Mcm5</td><td>Minichromosome maintenance complex component 5</td><td>0.47</td><td>0.26</td></tr><tr><td>ENSMUSG00000034906</td><td>Ncaph</td><td>Non-SMC condensin I complex subunit H</td><td>0.47</td><td>0.27</td></tr><tr><td>ENSMUSG00000006398</td><td>Cdc20</td><td>Cell division cycle 20</td><td>0.48</td><td>0.29</td></tr><tr><td>ENSMUSG00000037313</td><td>Tacc3</td><td>Transforming acidic coiled-coil containing protein 3</td><td>0.48</td><td>0.36</td></tr><tr><td>ENSMUSG00000027699</td><td>Ect2</td><td>ect2 oncogene</td><td>0.48</td><td>0.26</td></tr><tr><td>ENSMUSG00000020330</td><td>Hmmr</td><td>Hyaluronan-mediated motility receptor (RHAMM)</td><td>0.50</td><td>0.28</td></tr><tr><td>ENSMUSG00000020649</td><td>Rrm2</td><td>Ribonucleotide reductase M2</td><td>0.50</td><td>0.26</td></tr><tr><td>ENSMUSG00000019942</td><td>Cdk1</td><td>Cyclin-dependent kinase 1</td><td>0.50</td><td>0.34</td></tr><tr><td>ENSMUSG00000024590</td><td>Lmnb1</td><td>Lamin B1</td><td>0.51</td><td>0.33</td></tr><tr><td>ENSMUSG00000037725</td><td>Ckap2</td><td>Cytoskeleton associated protein 2</td><td>0.55</td><td>0.42</td></tr><tr><th colspan="5">Upregulated genes in Dyrk2<sup>-/-</sup></th></tr><tr><th>ID</th><th>GeneSymbol</th><th>Description</th><th>Ratio of Dyrk2<sup>-/-</sup>per wild-type in the presence of SAG</th><th>Ratio of Dyrk2<sup>-/-</sup>per wild-type in the absence of SAG</th></tr><tr><td>ENSMUSG00000056673</td><td>Kdm5d</td><td>Lysine (K)-specific demethylase 5D</td><td>Inf</td><td>Inf</td></tr><tr><td>ENSMUSG00000068457</td><td>Uty</td><td>Ubiquitously transcribed tetratricopeptide repeat gene Y chromosome</td><td>Inf</td><td>Inf</td></tr><tr><td>ENSMUSG00000069049</td><td>Ddx3y</td><td>DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked</td><td>Inf</td><td>8278</td></tr><tr><td>ENSMUSG00000069045</td><td>Eif2s3y</td><td>Eukaryotic translation initiation factor 2 subunit three structural gene Y-linked</td><td>Inf</td><td>Inf</td></tr><tr><td>ENSMUSG00000112616</td><td>Gm47434</td><td>Predicted gene 47434</td><td>719</td><td>Inf</td></tr><tr><td>ENSMUSG00000025582</td><td>Nptx1</td><td>Neuronal pentraxin 1</td><td>4.74</td><td>11.91</td></tr><tr><td>ENSMUSG00000024164</td><td>C3</td><td>Complement component 3</td><td>4.47</td><td>11.59</td></tr><tr><td>ENSMUSG00000039457</td><td>Ppl</td><td>Periplakin</td><td>4.30</td><td>11.11</td></tr><tr><td>ENSMUSG00000025784</td><td>Clec3b</td><td>C-type lectin domain family three member b</td><td>3.99</td><td>8.60</td></tr><tr><td>ENSMUSG00000002944</td><td>Cd36</td><td>CD36 molecule</td><td>3.20</td><td>3.45</td></tr><tr><td>ENSMUSG00000035385</td><td>Ccl2</td><td>Chemokine (C-C motif) ligand 2</td><td>2.86</td><td>2.84</td></tr><tr><td>ENSMUSG00000095478</td><td>Gm9824</td><td>Predicted pseudogene 9824</td><td>2.60</td><td>4.14</td></tr><tr><td>ENSMUSG00000038642</td><td>Ctss</td><td>Cathepsin S</td><td>2.58</td><td>3.19</td></tr><tr><td>ENSMUSG00000043719</td><td>Col6a6</td><td>Collagen type VI alpha 6</td><td>2.44</td><td>4.64</td></tr><tr><td>ENSMUSG00000033327</td><td>Tnxb</td><td>Tenascin XB</td><td>2.37</td><td>3.61</td></tr><tr><td>ENSMUSG00000069516</td><td>Lyz2</td><td>Lysozyme 2</td><td>2.30</td><td>3.08</td></tr><tr><td>ENSMUSG00000016494</td><td>Cd34</td><td>CD34 antigen</td><td>2.29</td><td>2.26</td></tr><tr><td>ENSMUSG00000042129</td><td>Rassf4</td><td>Ras association (RalGDS/AF-6) domain family member 4</td><td>2.29</td><td>3.43</td></tr><tr><td>ENSMUSG00000004730</td><td>Adgre1</td><td>Adhesion G-protein-coupled receptor E1</td><td>2.27</td><td>2.49</td></tr><tr><td>ENSMUSG00000030144</td><td>Clec4d</td><td>C-type lectin domain family member d</td><td>2.26</td><td>3.74</td></tr><tr><td>ENSMUSG00000029816</td><td>Gpnmb</td><td>Glycoprotein (transmembrane) nmb</td><td>2.22</td><td>2.66</td></tr><tr><td>ENSMUSG00000042286</td><td>Stab1</td><td>Stabilin 1</td><td>2.18</td><td>2.70</td></tr><tr><td>ENSMUSG00000020120</td><td>Plek</td><td>Pleckstrin</td><td>2.18</td><td>2.99</td></tr><tr><td>ENSMUSG00000040254</td><td>Sema3d</td><td>Sema domain immunoglobulin domain (Ig) short basic domain secreted (semaphorin) 3D</td><td>2.17</td><td>2.89</td></tr><tr><td>ENSMUSG00000005268</td><td>Prlr</td><td>Prolactin receptor</td><td>2.17</td><td>4.44</td></tr><tr><td>ENSMUSG00000024621</td><td>Csf1r</td><td>Colony-stimulating factor one receptor</td><td>2.10</td><td>2.74</td></tr><tr><td>ENSMUSG00000074896</td><td>Ifit3</td><td>Interferon-induced protein with tetratricopeptide repeats 3</td><td>2.04</td><td>3.96</td></tr><tr><td>ENSMUSG00000002985</td><td>Apoe</td><td>Apolipoprotein E</td><td>2.03</td><td>2.51</td></tr><tr><td>ENSMUSG00000057137</td><td>Tmem140</td><td>Transmembrane protein 140</td><td>2.02</td><td>3.18</td></tr><tr><td>ENSMUSG00000002289</td><td>Angptl4</td><td>Angiopoietin-like 4</td><td>2.02</td><td>5.94</td></tr><tr><td>ENSMUSG00000050335</td><td>Lgals3</td><td>Lectin galactose binding soluble 3</td><td>1.99</td><td>2.66</td></tr><tr><td>ENSMUSG00000090877</td><td>Hspa1b</td><td>Heat-shock protein 1B</td><td>1.98</td><td>2.13</td></tr><tr><td>ENSMUSG00000054404</td><td>Slfn5</td><td>Schlafen 5</td><td>1.96</td><td>3.77</td></tr><tr><td>ENSMUSG00000031209</td><td>Heph</td><td>Hephaestin</td><td>1.92</td><td>2.48</td></tr><tr><td>ENSMUSG00000027996</td><td>Sfrp2</td><td>Secreted frizzled-related protein 2</td><td>1.91</td><td>5.68</td></tr><tr><td>ENSMUSG00000050953</td><td>Gja1</td><td>Gap junction protein alpha 1</td><td>1.90</td><td>2.45</td></tr><tr><td>ENSMUSG00000005413</td><td>Hmox1</td><td>Heme oxygenase 1</td><td>1.90</td><td>1.97</td></tr><tr><td>ENSMUSG00000046805</td><td>Mpeg1</td><td>Macrophage expressed gene 1</td><td>1.85</td><td>2.57</td></tr><tr><td>ENSMUSG00000022037</td><td>Clu</td><td>Clusterin</td><td>1.83</td><td>3.06</td></tr><tr><td>ENSMUSG00000026389</td><td>Steap3</td><td>STEAP family member 3</td><td>1.81</td><td>2.24</td></tr><tr><td>ENSMUSG00000041577</td><td>Prelp</td><td>Proline arginine-rich end leucine-rich repeat</td><td>1.81</td><td>2.01</td></tr><tr><td>ENSMUSG00000027339</td><td>Rassf2</td><td>Ras association (RalGDS/AF-6) domain family member 2</td><td>1.80</td><td>2.72</td></tr></tbody></table></table-wrap><p>These findings collectively support the potential mechanism that DYRK2 governs ciliogenesis by, at least in part, maintaining the expression of <italic>Aurka</italic> and other disassembly genes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>DYRK2 is a positive regulator of Hh signaling</title><p>Although evidence indicates that DYRK2 plays important roles in the development of lower eukaryotes (<xref ref-type="bibr" rid="bib40">Pellettieri et al., 2003</xref>; <xref ref-type="bibr" rid="bib39">Pang et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Lu and Mains, 2007</xref>), little is known regarding the functions of DYRK2 in mammalian development. In the present study, we demonstrate for the first time that DYRK2 is required for normal Hh signaling and embryogenesis in vivo. Varjosalo et al. have established a human full-length protein kinase cDNA and corresponding kinase activity-deficient mutant library, and they reported that DYRK2 functions as a negative regulator of Hh signaling via direct phosphorylation and induction of the proteasome-dependent degradation of GLIs using in vitro over-expression approaches (<xref ref-type="bibr" rid="bib54">Varjosalo et al., 2008</xref>). In sharp contrast, our present study demonstrated using knockout approaches that endogenous protein levels of GLI2, and marginally the ratio of GLI3<sup>REP</sup>/GLI3<sup>FL</sup>, are decreased by deletion of <italic>Dyrk2</italic> in vitro after SAG-treatment. Consistently, <italic>Dyrk2<sup>-/-</sup></italic> embryos exhibited some typical phenotypes of inactivation of Hh signaling in vivo as indicated by abnormal responses but not the elimination of ligands. Taken together with the observed loss of <italic>Gli1</italic> induction in <italic>Dyrk2<sup>-/-</sup></italic> MEFs in vitro, we concluded that DYRK2 functions as a positive regulator of Hh signaling. GLI2 and GLI3, the key mediators of Hh signaling, are known to have specific and redundant functions (<xref ref-type="bibr" rid="bib31">Mo et al., 1997</xref>). In skeletal patterning during development, <italic>Dyrk2<sup>-/-</sup></italic> embryos exhibit phenotypes that are more similar to those of double <italic>Gli2</italic> and <italic>Gli3</italic> mutants than to those of each single mutant. Conversely, the deletion of other indispensable upstream Hh components such as <italic>Smo</italic> (<xref ref-type="bibr" rid="bib35">Norman et al., 2009</xref>), <italic>Ptch1 </italic>(<xref ref-type="bibr" rid="bib48">Svärd et al., 2006</xref>), <italic>Gpr161 </italic>(<xref ref-type="bibr" rid="bib16">Hwang et al., 2018</xref>), and <italic>SuFu </italic>(<xref ref-type="bibr" rid="bib48">Svärd et al., 2006</xref>) results in more severe defects that occur at earlier embryonic stages. The present data do not rule out the possibility that DYRK2 directly regulates Hh components. Despite this, given the evidence that <italic>Dyrk2<sup>-/-</sup></italic> embryos and cells possess morphological abnormalities in primary cilia, it is clear that DYRK2 plays a pivotal role in regulating Hh signaling via the control of ciliogenesis.</p></sec><sec id="s3-2"><title><italic>Dyrk2</italic> is a novel ciliogenesis-related gene in mice</title><p>Intriguingly, we found that DYRK2 negatively regulates ciliogenesis. In <italic>Chlamydomonas</italic>, certain mutations that cause flagella to assemble to excessive length (i.e. negatively regulator of ciliogenesis) have been identified, and these include mutations in LF1 through LF5 (<xref ref-type="bibr" rid="bib59">Wilson et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Tam et al., 2013</xref>). Among these, LF2, LF4, and LF5 encode protein kinases and are homologs of vertebrate CCRK, MAK/ICK/MOK, and CDKL5, respectively. In addition to these genes, GSK3β also negatively regulates cilia and flagella length (<xref ref-type="bibr" rid="bib62">Yuan et al., 2012</xref>). Interestingly, DYRK2 belongs to the same kinase group as CCRK, MAK/ICK/MOK, CDKL5, and GSK3β (the CMGC group) (<xref ref-type="bibr" rid="bib2">Becker and Sippl, 2011</xref>). To the best of our knowledge, however, the present study demonstrates for the first time that DYRK2 is a ciliogenesis-related gene and a negative regulator of ciliogenesis. Among these kinases, <italic>Dyrk2<sup>-/-</sup></italic> embryos exhibit similar phenotypes to <italic>Ick</italic>-deletion mice in vivo such as skeletal defects and cilia morphology, although they do not possess a hydrocephalus defect (<xref ref-type="bibr" rid="bib32">Moon et al., 2014</xref>). In response to <italic>Ick-</italic> or <italic>Mok-</italic>knockdown, cilia length depends on the activation of mTORC1 signaling (<xref ref-type="bibr" rid="bib3">Bolton et al., 2007</xref>). Our previous study reported the activation of mTORC1 signaling in <italic>DYRK2-</italic>knockdown human breast cancer cells (<xref ref-type="bibr" rid="bib30">Mimoto et al., 2017</xref>). As expected, mTORC1 signaling was slightly activated in <italic>Dyrk2<sup>-/-</sup></italic> MEFs; however, rapamycin, an inhibitor of mTORC1, did not significantly affect cilia length in <italic>Dyrk2<sup>-/-</sup></italic> MEFs. Thus, DYRK2 may control ciliogenesis through different mechanisms than those of other CMGC-kinases.</p></sec><sec id="s3-3"><title>DYRK2 is required for ciliogenesis and the dynamic trafficking of Hedgehog components in cilia</title><p>Abnormal ciliary trafficking of Hh components causes dysfunction in Hh signaling in several types of mutant mice (<xref ref-type="bibr" rid="bib12">He et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Moon et al., 2014</xref>). <italic>Dyrk2<sup>-/-</sup></italic> MEFs and embryos possessed disordered accumulation of Hh components (GLI2, GLI3, and SuFu) at cilia tips and exhibited elongation of cilia. On the other hand, SMO recruitment dependent on ligand stimulation was normally observed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs (<xref ref-type="fig" rid="fig10">Figure 10</xref>). Moreover, DYRK2 localizes at TZ, which acts as a selective barrier to control ciliary import and export of proteins (<xref ref-type="bibr" rid="bib10">Gerhardt et al., 2016</xref>). Given the findings that ciliary localization and ciliary disorders were observed in <italic>Dyrk2<sup>-/-</sup></italic> cells, DYRK2 could be involved in regulation of ciliary protein entry and exit. The functions of DYRK2 at TZ, however, remains to be elucidated.</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Schematic representation of DYRK2 in ciliogenesis and Hh signaling.</title><p>(Left panel) A schematic model of normal ciliogenesis and response to stimulation with Hh ligand. (Right panel) A schematic model ciliogenesis and response to stimulation with Hh ligand in <italic>Dyrk2</italic>-deletion. The morphology of primary cilia in <italic>Dyrk2<sup>-/-</sup></italic> MEFs was elongated and often bulged at the tips. In <italic>Dyrk2<sup>-/-</sup></italic> cells, downregulation of <italic>Aurka</italic> and other ciliary disassembly genes caused suppression of disassembly and elongation of primary cilia. Furthermore, abnormal ciliary trafficking caused accumulation of GLI2, GLI3, and SuFu in <italic>Dyrk2<sup>-/-</sup></italic> cells. Consequently, the induction of Hh signaling is drastically suppressed by deletion of <italic>Dyrk2.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57381-fig10-v1.tif"/></fig><p>As a first step to elucidate the functions of DYRK2 in cilia, we focused on factors involved in ciliary length control using a transcriptome approach, and we identified the downregulation of genes related to ciliary resorption mechanisms for proliferation in <italic>Dyrk2<sup>-/-</sup></italic> MEFs, such as <italic>Aurka</italic>, <italic>Plk1</italic>, <italic>Ube2c</italic>, <italic>Tpx2, Kif2c,</italic> and <italic>Cdc20</italic>. Among these, AURKA has been well-characterized as a disassembly factor, as transient knockdown by siRNA or treatment with an inhibitor of AURKA completely blocked ciliary disassembly during proliferation (<xref ref-type="bibr" rid="bib42">Pugacheva et al., 2007</xref>; <xref ref-type="bibr" rid="bib18">Inoko et al., 2012</xref>). In contrast to ciliary disassembly under proliferation, the function of AURKA for controlling ciliary length at steady state is unclear. In the present study, transient knockdown of <italic>Aurka</italic> under serum-starvation conditions induced elongation of cilia in a manner similar to that observed in <italic>Dyrk2<sup>-/-</sup></italic> MEFs. These data imply that the down-regulation of <italic>Aurka</italic> is, at least in part, associated with the phenotypes observed after deletion of <italic>Dyrk2.</italic> The expression of <italic>Aurka</italic> is known to be regulated by pathways such as YAP/TAZ (<xref ref-type="bibr" rid="bib22">Kim et al., 2015a</xref>) and AKT signaling (<xref ref-type="bibr" rid="bib41">Plotnikova et al., 2015</xref>). The molecular mechanisms underlying DYRK2-mediated <italic>Aurka</italic> regulation and ciliary trafficking remain unclear. Further research is required to elucidate these mechanisms.</p></sec><sec id="s3-4"><title>A possible relationship between DYRK2 and human ciliopathy</title><p>A number of syndromes caused by disorders involving ciliary proteins are categorized as skeletal ciliopathies, and these include short-rib thoracic dysplasia (SRTD), Jeune asphyxiating thoracic dystrophy (JATD), orofaciodigital syndrome (OFD), Ellis-van Creveld syndrome (EVC), and cranioectodermal dysplasia (CED) (<xref ref-type="bibr" rid="bib44">Reiter and Leroux, 2017</xref>). In mice, deletion of <italic>Dyrk2</italic> induces morphological abnormalities in primary cilia and skeletal defects in vivo. Additionally, DYRK2 is a ciliary protein that is primarily localized at the basal body and the TZ, which contains a growing number of ciliopathy proteins (<xref ref-type="bibr" rid="bib43">Reiter et al., 2012</xref>). While the present study does not include any evidence to support the relationship between DYRK2 and human disease, our results do suggest a possibility that <italic>DYRK2</italic> is involved in human ciliopathy, particularly in regard to skeletal disorders. Further investigations involving exome sequencing or genome-wide association studies using human patients will prove useful to clarify this issue.</p></sec><sec id="s3-5"><title>Conclusion</title><p>In summary, we identified DYRK2 as a novel mammalian ciliogenesis-related gene in vivo and in vitro. Deletion of <italic>Dyrk2</italic> induces abnormal ciliary morphology and trafficking of Hh pathway components and suppresses Hh signaling during mouse embryogenesis. The abnormal ciliogenesis in <italic>Dyrk2<sup>-/-</sup></italic> cells is partially caused by downregulation of <italic>Aurka</italic> and other disassembly genes. These findings will allow for a more complete understanding of the molecular mechanisms underlying embryogenesis, ciliogenesis, and human ciliopathy.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Dyrk2</italic><sup>-/-</sup> mouse</td><td>This paper</td><td>N/A</td><td>Maintained in K. Yoshida lab.</td></tr><tr><td>Cell line (<italic>M. musculus</italic>)</td><td>Wild-type and <italic>Dyrk2</italic><sup>-/-</sup> MEFs</td><td>This paper</td><td>N/A</td><td>Maintained in K. Yoshida lab.</td></tr><tr><td>Cell line (<italic>H. sapiens</italic>)</td><td>hTERT-RPE1</td><td>ATCC</td><td>Cat# CRL-4000 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_4388">CVCL_4388</ext-link></td><td/></tr><tr><td>Transfected construct (<italic>M. musculus</italic>)</td><td>mouse <italic>Aurka</italic>/pEGFP-C1</td><td>This paper</td><td>N/A</td><td>See Materials and methods subsection ‘Plasmid constructs’</td></tr><tr><td>Transfected construct (<italic>M. musculus</italic>)</td><td>mouse <italic>Dyrk2</italic>/FN22K-Halo Tag-CMVd1-Flexi-vector</td><td>This paper</td><td>N/A</td><td>See Materials and methods subsection ‘Plasmid constructs’</td></tr><tr><td>Transfected construct (<italic>M. musculus</italic>)</td><td><italic>Dyrk2</italic> targeting vector</td><td>Knockout Mouse Project Repository</td><td>PG00105_X_1_G09, PG00105_X_1_E04</td><td>See Materials and methods subsection ‘Plasmid constructs’</td></tr><tr><td>Recombinant DNA regent</td><td>Plasmid pEGFP-C1 <break/>(empty vector)</td><td>TaKaRa Bio</td><td>Cat# 6084–1</td><td> <break/><break/></td></tr><tr><td>Recombinant DNA regent</td><td>Plasmid pFN22K-Halo Tag-CMVd1-Flexi-vector (empty vector)</td><td>Promega</td><td>Cat# G2851</td><td/></tr><tr><td>Transfected construct (<italic>M. musculus</italic>)</td><td><italic>Dyrk2</italic> targeting vector</td><td>Knockout Mouse Project Repository</td><td>PG00105_X_1_G09, PG00105_X_1_E04</td><td/></tr><tr><td>Biological sample (Adenovirus)</td><td>Adenovirus-<italic>Cre</italic></td><td><xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2019.02.046">10.1016/j.canlet.2019.02.046</ext-link>.</td><td>N/A</td><td/></tr><tr><td>Biological sample (Adenovirus)</td><td>Adenovirus-human <italic>DYRK2</italic></td><td><xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2019.02.046">10.1016/j.canlet.2019.02.046</ext-link>.</td><td>N/A</td><td/></tr><tr><td>Biological sample (Adenovirus)</td><td>Adenovirus-human <italic>DYRK2-K251R</italic></td><td><xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2019.02.046">10.1016/j.canlet.2019.02.046</ext-link>.</td><td>N/A</td><td/></tr><tr><td>Biological sample (Adenovirus)</td><td>Adenovirus-GFP</td><td><xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref> doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2019.02.046">10.1016/j.canlet.2019.02.046</ext-link>.</td><td>N/A</td><td/></tr><tr><td>Antibody</td><td>Anti-Acetylated-tubulin (Mouse monoclonal)</td><td>Sigma-Aldrich</td><td>Cat# T7451, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_">AB_</ext-link>609894</td><td>ICC (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-ARL13B (Mouse monoclonal)</td><td>Abcam</td><td>Cat# ab136648,N/A</td><td>ICC (1:300)</td></tr><tr><td rowspan="2">Antibody</td><td rowspan="2">Anti-ARL13B (Rabbit polyclonal)</td><td rowspan="2">Proteintech</td><td rowspan="2">Cat# 17711–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2060867">AB_2060867</ext-link></td><td>ICC (1:400)</td></tr><tr><td>IHC (1:400)</td></tr><tr><td>Antibody</td><td>Anti-AURKA (Mouse monoclonal)</td><td>BD Transduction</td><td>Cat# 610938, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_398251">AB_398251</ext-link></td><td>WB (1:1000)</td></tr><tr><td rowspan="2">Antibody</td><td rowspan="2">Anti-DYRK2 (Rabbit polyclonal)</td><td rowspan="2">Sigma-Aldrich</td><td rowspan="2">Cat# HPA027230, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1847925">AB_1847925</ext-link></td><td>WB (1:1000)</td></tr><tr><td>ICC (1:400)</td></tr><tr><td>Antibody</td><td>Anti-FOXA2 (Mouse monoclonal)</td><td>Developmental Studies Hybridoma Bank</td><td>Cat# 4C7, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_528207">AB_528207</ext-link></td><td>IHC (1:8)</td></tr><tr><td>Antibody</td><td>Anti-CP110 (Rabbit polyclonal)</td><td>Proteintech</td><td>Cat# 12780–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10638480">AB_10638480</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-GAPDH (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-32233, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_627679">AB_627679</ext-link></td><td>WB (1:3000)</td></tr><tr><td>Antibody</td><td>Anti-GFP (Chicken polyclonal IgY)</td><td>Aves Labs</td><td>Cat# GFP-1020, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10000240">AB_10000240</ext-link></td><td>ICC (1:500)</td></tr><tr><td>Antibody</td><td>Anti-GFP (Rabbit monoclonal)</td><td>Abcam</td><td>Cat# ab183734, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2732027">AB_2732027</ext-link></td><td>WB (1:30000)</td></tr><tr><td rowspan="2">Antibody</td><td rowspan="2">Anti-GLI1 (Rabbit polyclonal)</td><td rowspan="2">Cell Signaling Technology</td><td rowspan="2">Cat# 2534, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2294745">AB_2294745</ext-link></td><td>WB (1:500)</td></tr><tr><td>ICC (1:100)</td></tr><tr><td rowspan="3">Antibody</td><td rowspan="3">Anti-GLI2 (Goat polyclonal)</td><td rowspan="3">R and D systems</td><td rowspan="3">Cat# AF3635, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2111902">AB_2111902</ext-link></td><td>WB (1:500)</td></tr><tr><td>ICC (1:50)</td></tr><tr><td>IHC (1:50)</td></tr><tr><td rowspan="3">Antibody</td><td rowspan="3">Anti-GLI3 (Goat polyclonal)</td><td rowspan="3">R and D systems</td><td rowspan="3">Cat# AF3690, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2232499">AB_2232499</ext-link></td><td>WB (1:200)</td></tr><tr><td>ICC (1:100)</td></tr><tr><td>IHC (1:150)</td></tr><tr><td>Antibody</td><td>Anti-gamma-tubulin (Goat polyclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-7396, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2211262">AB_2211262</ext-link></td><td>ICC (1:3500)</td></tr><tr><td rowspan="2">Antibody</td><td rowspan="2">Anti-gamma-tubulin (Mouse monoclonal)</td><td rowspan="2">Santa Cruz Biotechnology</td><td rowspan="2">Cat# sc-17787, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_628417">AB_628417</ext-link></td><td>ICC (1:400)</td></tr><tr><td>IHC (1:400)</td></tr><tr><td>Antibody</td><td>Anti-HaloTag (Rabbit polyclonal)</td><td>Promega</td><td>Cat# G9281, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_713650">AB_713650</ext-link></td><td>ICC (1:700)</td></tr><tr><td>Antibody</td><td>Anti-IFT140 (Rabbit polyclonal)</td><td>Proteintech</td><td>Cat# 17460–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2295648">AB_2295648</ext-link></td><td>ICC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-IFT81 (Rabbit polyclonal)</td><td>Proteintech</td><td>Cat# 11744–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2121966">AB_2121966</ext-link></td><td>ICC (1:50)</td></tr><tr><td>Antibody</td><td>Anti-IFT88 (Rabbit polyclonal)</td><td>Proteintech</td><td>Cat# 13967–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2121979">AB_2121979</ext-link></td><td>ICC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-KATANIN p60 (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-373814, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11014191">AB_11014191</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-KI67 (Rabbit monoclonal)</td><td>Abcam</td><td>Cat# ab16667, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_302459">AB_302459</ext-link></td><td>ICC (1:500)</td></tr><tr><td>Antibody</td><td>Anti-NPHP1 (Mouse monoclonal)</td><td>SIGMA-Aldrich</td><td>Cat# MABS2185,N/A</td><td>ICC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-mTORC1 (Rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 2972, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330978">AB_330978</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-NKX2.2 (Mouse monoclonal)</td><td>Developmental Studies Hybridoma Bank</td><td>Cat# 74.5A5, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_531794">AB_531794</ext-link></td><td>IHC (1:10)</td></tr><tr><td>Antibody</td><td>Anti-NKX6.1 (Mouse monoclonal)</td><td>Developmental Studies Hybridoma Bank</td><td>Cat# F55A10, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_532378">AB_532378</ext-link></td><td>IHC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-OLIG2 (Rabbit monoclonal)</td><td>abcam</td><td>Cat# ab109186, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10861310">AB_10861310</ext-link></td><td>IHC (1:500)</td></tr><tr><td>Antibody</td><td>Anti-PAX6 (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-81649, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1127044">AB_1127044</ext-link></td><td>IHC (1:400)</td></tr><tr><td>Antibody</td><td>Anti-Phosho-S6 (Ser 235/236) (Rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 2211, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331679">AB_331679</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-P-4EBP1(Thr 37/46) (Rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 2855, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_560835">AB_560835</ext-link></td><td>WB (1:1500)</td></tr><tr><td>Antibody</td><td>Anti-SMO (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-166685, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2239686">AB_2239686</ext-link></td><td>ICC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-SuFu (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-137014, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2197315">AB_2197315</ext-link></td><td>ICC (1:100)</td></tr><tr><td>Antibody</td><td>Anti-S6 (Rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 2217, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331355">AB_331355</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-4EBP1 (Rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 9644, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2097841">AB_2097841</ext-link></td><td>WB (1:3000)</td></tr><tr><td>Sequence-based reagent</td><td>Human <italic>DYRK2</italic> siRNA#1</td><td>BEX</td><td>608481</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Human <italic>DYRK2</italic> siRNA#2</td><td>ThermoFisher Scientific</td><td>HSS112284</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Dyrk2</italic> siRNA#1</td><td>ThermoFisher Scientific</td><td>4390771 (s87545)</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Dyrk2</italic> siRNA#2</td><td>ThermoFisher Scientific</td><td>4390771 (s87546)</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Aurka</italic> siRNA#1</td><td>Integrated DNA Technologies</td><td>mm.Ri.Aurka.13.1</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Aurka</italic> siRNA#2</td><td>Integrated DNA Technologies</td><td>mm.Ri.Aurka.13.4</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Cdc20</italic> siRNA</td><td>Integrated DNA Technologies</td><td>mm.Ri.Cdc20.13.2</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Kif2c</italic> siRNA</td><td>Integrated DNA Technologies</td><td>mm.Ri.Kif2c.13.3</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Plk1</italic> siRNA</td><td>Integrated DNA Technologies</td><td>mm.Ri.Plk1.13.1</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Tpx2</italic> siRNA</td><td>Integrated DNA Technologies</td><td>mm.Ri.Tpx2.13.1</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Mouse <italic>Ube2c</italic> siRNA</td><td>Integrated DNA Technologies</td><td>mm.Ri.Ube2c.13.1</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Negative Control DsiRNA (siNegative)</td><td>Integrated DNA Technologies</td><td>51-01-14</td><td valign="bottom"/></tr><tr><td>Sequence-based reagent</td><td>Silencer Select Negative Control (siControl)</td><td>ThermoFisher Scientific</td><td>4390843</td><td valign="bottom"/></tr><tr><td>Chemical compound, drug</td><td>InSolution SAG</td><td>Merck</td><td>566660</td><td valign="bottom"/></tr><tr><td>Chemical compound, drug</td><td>Rapamycin</td><td>LC Laboratories</td><td>R-5000</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td>BZ-X800 Analyzer</td><td>Keyence</td><td>BZ-X800 Analyzer</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td>Excel</td><td>Microsoft</td><td>Mac2019</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td>Fusion</td><td>M and S Instruments</td><td>Fusion</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism 7</td><td>GraphPad Software Inc</td><td>Mac OS X</td><td valign="bottom"/></tr><tr><td>Software, algorithm</td><td>PikoReal Software 2.1</td><td>ThermoFisher Scientific</td><td>PikoReal Software 2.1</td><td valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Generation of <italic>Dyrk2</italic> knockout mice (<italic>Dyrk2<sup>-/-</sup></italic>)</title><p><italic>Dyrk2<sup>-/-</sup></italic> mice were generated using the knockout-first strategy (<xref ref-type="bibr" rid="bib46">Skarnes et al., 2011</xref>). A schematic representation of the targeted <italic>Dyrk2</italic> allele is provided in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. The <italic>Dyrk2</italic> targeting vector (PG00105_X_1_G09 and PG00105_X_1_E04) was obtained from the Knockout Mouse Project Repository (<italic>Dyrk2</italic> targeting project: 337–66440). Gene-targeting methods were performed according to standard protocols. Briefly, linearized vectors were electroporated into JM8A3.N1 embryonic stem (ES) cells. G418-resistant ES cell clones were analyzed using Southern blot analysis for the presence of the correct targeted-allele using BglII digestion and a 3’ external probe. Hybridization with the 3’ external probe detected 10.7 kb (wild-type allele) and 17.0 kb (targeted tm1a allele) BglII bands (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Six positive ES clones out of 240 clones were obtained. Chimeric mice were created by injection of the targeted ES cells into C57BL/6J blastocysts and were mated with C57BL/6J WT mice to establish germline-transmitted founders. Heterozygous knockout-first (<italic>Dyrk2</italic><sup>tm1a</sup>) mice were identified using Southern blotting. An exon three knockout allele (<italic>Dyrk2</italic><sup>tm1b</sup>) was generated by mating the <italic>Dyrk2</italic><sup>tm1a</sup> mice the with CAG-Cre mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). For genotyping and validation of knockout alleles, we performed PCR using the primers listed in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>List of primer sets.</title></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4">For genotyping</th></tr><tr><th>Gene</th><th colspan="2">Sequence (5'→3')</th><th>Accession number</th></tr><tr><td rowspan="2"><italic>Dyrk2 tm1b-WT</italic></td><td>Forward</td><td><named-content content-type="sequence">TGGGTCCAAATGCAAAGAAACGCCA</named-content></td><td rowspan="2">NC_000076.6</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCTTCTCGTTCCGCACCATCTTCAG</named-content></td></tr><tr><td rowspan="2"><italic>Dyrk2 tm1b-KO</italic></td><td>Forward</td><td><named-content content-type="sequence">CCTTCTCCCTCCTCCACTCTGACCCA</named-content></td><td rowspan="2">NC_000076.6</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">CCACACCTCCCCCTGAACCTGAAAC</named-content></td></tr><tr><th colspan="4">For amplification of the probes for in situ hybridization or Southern blotting</th></tr><tr><th>Gene</th><th colspan="2">Sequence (5'→3')</th><th>Accession number</th></tr><tr><td rowspan="2">Mouse <italic>Foxf2</italic></td><td>Forward</td><td><named-content content-type="sequence">GAGATTAACCCTCACTAAAGGGAGGTTATGGTGGCCTCGACAT</named-content></td><td rowspan="2">NM_010225.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GAGTAATACGACTCACTATAGGGACACACACACCTCCCTTTTCA</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Gli1</italic></td><td>Forward</td><td><named-content content-type="sequence">GAGTATTTAGGTGACACTATAGAAGCAGGGAAGAGAGCAGACTG</named-content></td><td rowspan="2">NM_010296.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GAGTAATACGACTCACTATAGGGGCTGAGTGTTGTCCAGGTC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Ptch1</italic></td><td>Forward</td><td><named-content content-type="sequence">GAGATTAACCCTCACTAAAGGGACATGGCCTCGGCTGGTAAC</named-content></td><td rowspan="2">NM_008957.3</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GAGTAATACGACTCACTATAGGGTGTACCCATGGCCAACTTCG</named-content></td></tr><tr><td rowspan="2">Southern for <italic>Dyrk2</italic></td><td>Forward</td><td><named-content content-type="sequence">CTTCGAATCCTTTTATCCTTCAGGC</named-content></td><td rowspan="2">NC_000076.6</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">ACATCATGTTCATTGGTTTTGCTCT</named-content></td></tr><tr><th colspan="4">For cloning</th></tr><tr><th>Gene</th><th colspan="2">Sequence (5'→3')</th><th>Accession number</th></tr><tr><td rowspan="2">Mouse <italic>Aurka CDS</italic></td><td>Forward</td><td><named-content content-type="sequence">GGACTCAGATCTCGAGACATGGCTGTTGAGGGCG</named-content></td><td rowspan="2">NM_011497.4</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GTCGACTGCAGAATTCCTAAGATGATTTGCTGGTTG</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Dyrk2 CDS</italic></td><td>Forward</td><td><named-content content-type="sequence">GTGCGCGATCGCCATGTTAACCAGGAAACCTTCGGC</named-content></td><td rowspan="2">NM_001014390.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">CTCCGTTTAAACGCTAACGAGTTTCGGCAACAC</named-content></td></tr><tr><th colspan="4">For real-time PCR</th></tr><tr><th>Gene</th><th colspan="2">Sequence (5'→3')</th><th>Accession number</th></tr><tr><td rowspan="2">Human <italic>DYRK2</italic></td><td>Forward</td><td><named-content content-type="sequence">GGGGAGAAAACGTCAGTGAA</named-content></td><td rowspan="2">NM_006482.3</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TCTGCGCCAAATTAGTCCTC</named-content></td></tr><tr><td rowspan="2">Human <italic>HPRT1</italic></td><td>Forward</td><td><named-content content-type="sequence">GGACTAATTATGGACAGGACTG</named-content></td><td rowspan="2">NM_000194.3</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCTCTTCAGTCTGATAAAATCTAC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Aurka</italic></td><td>Forward</td><td><named-content content-type="sequence">CACACGTACCAGGAGACTTACAGA</named-content></td><td rowspan="2">NM_011497.4</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">AGTCTTGAAATGAGGTCCCTGGCT</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Cdc20</italic></td><td>Forward</td><td><named-content content-type="sequence">GAGCTCAAAGGACACACAGC</named-content></td><td rowspan="2">NM_023223.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCCACAACCGTAGAGTCTCA</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Dyrk2</italic></td><td>Forward</td><td><named-content content-type="sequence">CTACCACTACAGCCCACACG</named-content></td><td rowspan="2">NM_001014390.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TCTGTCCGTGGCTGTTGA</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Foxf2</italic></td><td>Forward</td><td><named-content content-type="sequence">AGCATGTCTTCCTACTCGTTG</named-content></td><td rowspan="2">NM_010225.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TCTTTCCTGTCGCACACT</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Gli1</italic></td><td>Forward</td><td><named-content content-type="sequence">GCACCACATCAACAGTGAGC</named-content></td><td rowspan="2">NM_010296.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCGTCTTGAGGTTTTCAAGG</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Hprt</italic></td><td>Forward</td><td><named-content content-type="sequence">CTCATGGACTGATTATGGACAGGAC</named-content></td><td rowspan="2">NM_013556.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCAGGTCAGCAAAGAACTTATAGCC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Kif2c</italic></td><td>Forward</td><td><named-content content-type="sequence">GAGAGCAAGCTGACCCAGG</named-content></td><td rowspan="2">NM_134471.4</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">CCTGGTGAGATCATGGCGATC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Plk1</italic></td><td>Forward</td><td><named-content content-type="sequence">CCAAGCACATCAACCCAGTG</named-content></td><td rowspan="2">NM_011121.4</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TGAGGCAGGTAATAGGGAGACG</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Ptch1</italic></td><td>Forward</td><td><named-content content-type="sequence">CTCTGGAGCAGATTTCCAAGG</named-content></td><td rowspan="2">NM_008957.3</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TGCCGCAGTTCTTTTGAATG</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Shh</italic></td><td>Forward</td><td><named-content content-type="sequence">GTGAAGCTGCGAGTGACCG</named-content></td><td rowspan="2">NM_009170.3</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">CCTGGTCGTCAGCCGCCAGCACGC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Tpx2</italic></td><td>Forward</td><td><named-content content-type="sequence">GCGAGGTTGTCAGGTGTGTA</named-content></td><td rowspan="2">NM_001141977.1</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">TTGATAAAGTCGGTGGGGGC</named-content></td></tr><tr><td rowspan="2">Mouse <italic>Ube2c</italic></td><td>Forward</td><td><named-content content-type="sequence">CTGCTAGGAGAACCCAACATC</named-content></td><td rowspan="2">NM_026785.2</td></tr><tr><td>Reverse</td><td><named-content content-type="sequence">GCTGGAGACCTGCTTTGAATA</named-content></td></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title>Animal care</title><p>Mice were housed individually in a temperature-controlled room under a 12 hr light/dark cycle. Determination of pregnancy in mice was achieved by the observation of a vaginal plug on day 0.5 of gestation. Animals were euthanized by anesthesia. The animal experiment protocol was approved by the Institutional Animal Care and Use Committee of Jikei University (No. 2017–065 and 2018–031), and the studies were performed in accordance with the Guidelines for the Proper Conduct of Animal Experiments of the Science Council of Japan.</p></sec><sec id="s4-3"><title>Alcian blue and alizarin red staining</title><p>Euthanized wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mice at E18.5 and E16.5 were skinned, eviscerated, and fixed in 100% EtOH. For skeletal analysis, the embryos were stained with 1% Alcian Blue (Wako Pure Chemicals, Osaka, Japan) dissolved in 20% glacial acetic acid and 80% EtOH and 0.01% Alizarin Red (Sigma-Aldrich, St. Louis, MO) dissolved in 1% KOH. The excised tissues were observed using a stereo microscope (BioTools, Gunma, Japan). Ten embryos of each wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mice were analyzed.</p></sec><sec id="s4-4"><title>In situ hybridization</title><p>In situ hybridization was performed according to a previous report (<xref ref-type="bibr" rid="bib9">Fujiwara et al., 2007</xref>). Briefly, each digoxigenin (DIG)-labeled cRNA probe was amplified by PCR using primer sets (<xref ref-type="table" rid="table2">Table 2</xref>) and labeled using the Roche DIG RNA labeling kit (Merck, Schwalbach, Germany). Embryos at E10.5 and the heads of mice at E14.5 were fixed using MEMFA (2 mM EGTA, 1 mM MgSO4, and 3.7% formaldehyde) in 100 mM MOPS (pH 7.5) overnight at 4°C, and this was followed by immersion in 30% trehalose (Wako) in 20 mM HEPES to cryoprotect the tissues. Cryosections (7 μm thickness) from the transverse or sagittal plane were hybridized with DIG-labeled cRNA probe and were visualized with alkaline phosphatase-conjugated anti-DIG antibody (Merck) using 4-nitroblue tetrazolium chloride (NBT; Merck) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP; Merck). The sections were observed under a BZ-X800 microscope (KEYENCE, Osaka, Japan).</p></sec><sec id="s4-5"><title>Immunohistochemistry and hematoxylin and eosin (HE)-staining</title><p>Embryos at E10.5, E13.5, and E18.5 were fixed and sliced as described above. Depending on the antibody, the sections were antigen retrieved by an ImmunoSaver (Nisshin EM, Tokyo, Japan) for 60 min at 80°C. The sections were incubated with 10% (v/v) fetal bovine serum and 0.4% (v/v) Triton X-100 in HEPES buffer (blocking buffer). After washing, the sections were incubated with primary antibodies (Key resources table) in blocking buffer at 4°C overnight. After the immunoreaction, the sections were incubated with secondary antibodies using Cy3-, Cy5-, or FITC-conjugated AffiniPure donkey anti-goat, rabbit, and mouse IgG (Jackson ImmunoResearch, West Grove, PA). The sections were washed and incubated in VECTASHIELD Mounting Medium (Vector Laboratories, Burlingame, CA) containing 4,6′-diamidino-2-phenylindole dihydrochloride (DAPI). For HE-staining, the sections were stained using standard procedures. The sections were observed under a BZ-X800 fluorescence microscope (KEYENCE).</p></sec><sec id="s4-6"><title>Scanning electron microscopy (SEM)</title><p>Wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E10.5 were washed with 0.1 M phosphate buffer (PB) (pH7.5) and fixed with 2% glutaraldehyde (TAAB Laboratories Equipment, Berkshire, England) in 0.1 M PB (pH 7.4) for 1 week at 4°C. The embryos were placed in tannic acid in 0.1 M PB for 2 hr at room temperature in darkness, and then immersed in 1% OsO<sub>4</sub> solution for 2 hr at room temperature. After dehydration in graded ethanol, the samples were transferred into isoamyl acetate and dried at the critical point in liquid CO<sub>2</sub>, and this was followed by a metal coating procedure (Hitachi, Tokyo, Japan). The surfaces of tissues were then observed using scanning electron microscopy (Hitachi).</p></sec><sec id="s4-7"><title>Plasmid constructs</title><p>Full-length cDNA fragments of mouse <italic>Dyrk2</italic> and <italic>Aurka</italic> were amplified by PCR and cloned in frame into the pFN22K-HaloTag-CMVd1-Flexi-vector (Promega, Madison, WI) and pEGFP-C1 (TaKaRa Bio, Otsu, Japan), respectively. The nucleotide sequences of the primers used are listed in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s4-8"><title>Cell culture and transfection</title><p>Primary mouse embryonic fibroblast (MEFs) were generated from wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos at E13.5. MEFs and immortalized human retinal pigment epithelia cells (hTERT-RPE1; Cat# CRL-4000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_4388">CVCL_4388</ext-link>, ATCC, Manassas, VA) were cultured in DMEM (nacalai tesque, Kyoto, Japan) with 10% FBS (biowest, Nuaille, France), 1% GultaMAX (Gibco, Gaithersburg, MD), and 1% Penicillin-streptomycin (nacalai tesque) at 37°C under 5% CO<sub>2</sub>. hTERT-RPE1 cells were authenticated by the STR profiling and negative for mycoplasma contamination. To induce ciliogenesis, cells were grown to 80–90% confluency and serum-starved (0.5% FBS) for 24 hr. For SAG-stimulation, cells were treated with 100 nM SAG (Merck) for 24 hr after serum-starvation. For rapamycin-stimulation, cells were treated with 0.5 µM rapamycin (LC Laboratories, Woburn, MA) for 24 hr after serum-starvation. Transient knockdown was achieved using the Lipofectamine RNAiMAX transfection regent (ThermoFisher Scientific, Waltham, MA) for 48 hr under serum-starvation conditions according to the manufacturer’s instructions with a final concentration of 6–20 nM siRNA (Key resources table). For over-expression of DYRK2-HaloTag, transfection was performed using X-tremeGENE9 (Merck) for hTERT-RPE1 cells according to the manufacturer’s instructions and the cells were cultured for 24 hr under serum-starvation condition for ciliogenesis. For over-expression of AURKA-EGFP or EGFP, transfection was performed using Xfect (TaKaRa Bio) for MEFs according to the manufacturer’s instructions, and the cells were cultured for 24 hr under serum-starvation condition for ciliogenesis.</p></sec><sec id="s4-9"><title>Adenovirus infection</title><p>Adenovirus construction and infections were performed according to a previous report (<xref ref-type="bibr" rid="bib28">Maekawa et al., 2013</xref>; <xref ref-type="bibr" rid="bib60">Yokoyama-Mashima et al., 2019</xref>). Briefly, Flag-DYRK2 and Flag-DYRK2-K251R (<xref ref-type="bibr" rid="bib50">Taira et al., 2010</xref>; <xref ref-type="bibr" rid="bib29">Mimoto et al., 2013</xref>) were expressed depending upon <italic>Cre</italic>-expression. Following infection at a MOI (multiplicity of infection) of 100, MEFs were extracted for gene-expression analysis at 60 hr post-infection. MOI for MEFs was determined using an adenovirus construct for GFP-expression.</p></sec><sec id="s4-10"><title>Immunoblotting</title><p>Tissues (the limb buds at E13.5) and MEFs were washed in twice and lysed using RIPA buffer containing several inhibitors (1 mM PMSF, 10 µg/ml Aprotinin, 1 µg/ml Leupeptin, 1 µg/ml Pepstatin A, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 10 mM NaF, and 1 mM DTT). Equal amounts of protein (5 µg) were resolved on 4–15% Mini-PROTEA TGX Precast Protein Gels (BioRad, Hercules, CA). After electrophoresis, proteins were transferred to PVDF membranes (Merck). Membranes were blocked with 5% skim milk in tris-buffered saline (TBS) containing 0.05% Tween 20 (TBST) or 0.1% casein/gelatin in TBST, depending on the antibody. Primary and secondary antibodies were reacted in each blocking buffer (Key resources table). Signals were detected using a chemiluminescent regent, ImmunoStar LD (Wako). Signals were observed and band intensity was measured using a Fusion-Solo system (M and S Instruments, Tokyo, Japan).</p></sec><sec id="s4-11"><title>Quantitative real-time polymerase chain reaction (qPCR)</title><p>Total RNAs were prepared from tissues (the limbs of E13.5, the mandibular arches of E10.5, and whole embryos at E9.5) and MEFs using the RNeasy mini kit (QIAGEN, Germantown, MD) or ISOGEN II (Nippon Gene, Tokyo, Japan), respectively. Reverse transcripts were obtained using PrimeScript Reverse Transcriptase (TaKaRa Bio) and subjected to qPCR using a PIKOREAL96 system (ThermoFisher Scientific). Reactions were performed in KAPA SYBR FAST qPCR Master Mix (NIPPON Genetics, Tokyo, Japan) that included 0.2 μM of a specific primer set for each gene (<xref ref-type="table" rid="table2">Table 2</xref>). Data were calculated by the comparative C<sub>T</sub> method (ΔC<sub>T</sub> method) to estimate the mRNA copy number relative to that of <italic>Hprt</italic> as an internal standard. The DNA sequence of the PCR product was confirmed by nucleotide sequencing (data not shown).</p></sec><sec id="s4-12"><title>Immunocytochemistry</title><p>For immunocytochemistry, MEFs and hTERT-RPE1 cells were cultured on 8-well chamber slides (ThermoFisher Scientific) coated with Poly-D-lysin (Sigma-Aldrich). Cells were fixed and antigen retrieved depending on the antibody. The primary antibody reaction was performed at an appropriate dilution (Key resources table) in the presence of blocking buffer at 4°C overnight. After immunoreactions, cells were incubated with secondary antibodies using Cy3-, Cy5-, or FITC-conjugated AffiniPure donkey anti-goat, rabbit, and mouse IgG, and chicken IgY (Jackson ImmunoResearch). The cells were then washed and incubated with DAPI. Immunofluorescence was observed under a BZ-X800 fluorescence microscope (KEYENCE).</p></sec><sec id="s4-13"><title>RNA-Seq</title><p>Total RNAs were prepared from MEFs cultured in the absence or presence of 100 nM SAG for 24 hr using RNeasy mini kit (QIAGEN) with DNase I treatment (QIAGEN). Materials were enriched for polyA sequences, and quantitative RNA-sequencing was performed using an Illumina HiSeq (Illumina, San Diego, CA). Cutadapt v1.9.1 was used to trim and filter reads, and clean data were aligned to the reference genome (ENSEMBLE, GRCm38.97) using the software HISAT 2 (v2.0.1). Relative gene expression was quantified and normalized in a FPKM (fragments per kilobase of transcript per million mapped reads) format.</p></sec><sec id="s4-14"><title>STRING and gene ontology (GO) analysis</title><p>To determine the presence of interactions/partnerships among downregulated genes in <italic>Dyrk2<sup>-/-</sup></italic> MEFs, protein-protein interaction networks were extracted from the STRING database (<ext-link ext-link-type="uri" xlink:href="https://string-db.org">https://string-db.org</ext-link>) and drawn by STRING v11. Gene ontology (GO) analysis was also performed using STRING v11 to demonstrate the biological processes enriched in the altered genes. The resulting GO terms that possessed a false discovery rate (FDR) of less than 0.005 were considered as enriched biological processes.</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>Each experiment was confirmed by at least three independent biological replicates per condition. Data are presented as the means ± SEM. Prism seven software (GraphPad, San Diego, CA, USA) was used for statistical analyses. Means between two groups were compared using the Student’s <italic>t</italic>-test. Multiple inter-group differences were analyzed by one-way ANOVA (analysis of variance) followed by Tukey’s multiple comparison test.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Yuki Kobayashi at Hiroshima University for constructive suggestions. This work was partially supported by JSPS KAKENHI (grant numbers 19K16781 to Saishu Yoshida and 17H03584, 18K19484, and 20H03519 to Kiyotsugu Yoshida), the Platform of Advanced Animal Model Support from MEXT of Japan (to Kiyotsugu Yoshida), the Jikei University Research Fund (to Saishu Yoshida), and the Takeda Science Foundation (to Saishu Yoshida).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation, Visualization</p></fn><fn fn-type="con" id="con7"><p>Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Validation, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The animal experiment protocol was approved by the Institutional Animal Care and Use Committee of Jikei University (No. 2017-065 and 2018-031), and the studies were performed in accordance with the Guidelines for the Proper Conduct of Animal Experiments of the Science Council of Japan.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-57381-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Data except for RNA-seq in this study are included in the manuscript and supporting files. Source data files have been provided: Figure 2-source data 1 Figure 2-figure supplement 1-source data 1 Figure 3-source data 1 Figure 3-source data 2 Figure 3-figure supplement 1-source data 1 Figure 3-figure supplement 2-source data 1 Figure 4-source data 1 Figure 4-figure supplement 1-source data 1 Figure 4-figure supplement 2-source data 1 Figure 4-figure supplement 3-source data 1 Figure 6-source data 1 Figure 6-figure supplement 3-source data 1 Figure 7-source data 1 Figure 8-source data 1 Figure 9-source data 1. RNA-seq data have been deposited in Dryad under accession code URL <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.pnvx0k6j8">https://doi.org/10.5061/dryad.pnvx0k6j8</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Aoki</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Nakakura</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name><name><surname>Yogosawa</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis</data-title><source>Dryad Digital Repository</source><pub-id assigning-authority="Dryad" pub-id-type="doi">10.5061/dryad.pnvx0k6j8</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bangs</surname> <given-names>F</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Primary cilia and mammalian hedgehog signaling</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>9</volume><elocation-id>a028175</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a028175</pub-id><pub-id pub-id-type="pmid">27881449</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>W</given-names></name><name><surname>Sippl</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Activation, regulation, and inhibition of DYRK1A</article-title><source>FEBS Journal</source><volume>278</volume><fpage>246</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07956.x</pub-id><pub-id pub-id-type="pmid">21126318</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname> <given-names>EC</given-names></name><name><surname>So</surname> <given-names>AY</given-names></name><name><surname>Chaivorapol</surname> <given-names>C</given-names></name><name><surname>Haqq</surname> <given-names>CM</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cell- and gene-specific regulation of primary target genes by the androgen receptor</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>2005</fpage><lpage>2017</lpage><pub-id pub-id-type="doi">10.1101/gad.1564207</pub-id><pub-id pub-id-type="pmid">17699749</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broekhuis</surname> <given-names>JR</given-names></name><name><surname>Verhey</surname> <given-names>KJ</given-names></name><name><surname>Jansen</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of cilium length and intraflagellar transport by the RCK-kinases ICK and MOK in renal epithelial cells</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e108470</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0108470</pub-id><pub-id pub-id-type="pmid">25243405</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>MH</given-names></name><name><surname>Wilson</surname> <given-names>CW</given-names></name><name><surname>Li</surname> <given-names>YJ</given-names></name><name><surname>Law</surname> <given-names>KK</given-names></name><name><surname>Lu</surname> <given-names>CS</given-names></name><name><surname>Gacayan</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Hui</surname> <given-names>CC</given-names></name><name><surname>Chuang</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cilium-independent regulation of gli protein function by sufu in hedgehog signaling is evolutionarily conserved</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>1910</fpage><lpage>1928</lpage><pub-id pub-id-type="doi">10.1101/gad.1794109</pub-id><pub-id pub-id-type="pmid">19684112</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname> <given-names>E</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network</article-title><source>Development</source><volume>135</volume><fpage>2489</fpage><lpage>2503</lpage><pub-id pub-id-type="doi">10.1242/dev.009324</pub-id><pub-id pub-id-type="pmid">18621990</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguether</surname> <given-names>T</given-names></name><name><surname>San Agustin</surname> <given-names>JT</given-names></name><name><surname>Keady</surname> <given-names>BT</given-names></name><name><surname>Jonassen</surname> <given-names>JA</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Francis</surname> <given-names>R</given-names></name><name><surname>Tobita</surname> <given-names>K</given-names></name><name><surname>Johnson</surname> <given-names>CA</given-names></name><name><surname>Abdelhamed</surname> <given-names>ZA</given-names></name><name><surname>Lo</surname> <given-names>CW</given-names></name><name><surname>Pazour</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFT27 links the BBSome to IFT for maintenance of the ciliary signaling compartment</article-title><source>Developmental Cell</source><volume>31</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.09.011</pub-id><pub-id pub-id-type="pmid">25446516</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everson</surname> <given-names>JL</given-names></name><name><surname>Fink</surname> <given-names>DM</given-names></name><name><surname>Yoon</surname> <given-names>JW</given-names></name><name><surname>Leslie</surname> <given-names>EJ</given-names></name><name><surname>Kietzman</surname> <given-names>HW</given-names></name><name><surname>Ansen-Wilson</surname> <given-names>LJ</given-names></name><name><surname>Chung</surname> <given-names>HM</given-names></name><name><surname>Walterhouse</surname> <given-names>DO</given-names></name><name><surname>Marazita</surname> <given-names>ML</given-names></name><name><surname>Lipinski</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sonic hedgehog regulation of <italic>Foxf2</italic> promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis</article-title><source>Development</source><volume>144</volume><fpage>2082</fpage><lpage>2091</lpage><pub-id pub-id-type="doi">10.1242/dev.149930</pub-id><pub-id pub-id-type="pmid">28506991</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname> <given-names>K</given-names></name><name><surname>Maekawa</surname> <given-names>F</given-names></name><name><surname>Kikuchi</surname> <given-names>M</given-names></name><name><surname>Takigami</surname> <given-names>S</given-names></name><name><surname>Yada</surname> <given-names>T</given-names></name><name><surname>Yashiro</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Expression of retinaldehyde dehydrogenase (RALDH)2 and RALDH3 but not RALDH1 in the developing anterior pituitary glands of rats</article-title><source>Cell and Tissue Research</source><volume>328</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1007/s00441-006-0345-7</pub-id><pub-id pub-id-type="pmid">17180597</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname> <given-names>C</given-names></name><name><surname>Wiegering</surname> <given-names>A</given-names></name><name><surname>Leu</surname> <given-names>T</given-names></name><name><surname>Rüther</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Control of hedgehog signalling by the Cilia-Regulated proteasome</article-title><source>Journal of Developmental Biology</source><volume>4</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.3390/jdb4030027</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haycraft</surname> <given-names>CJ</given-names></name><name><surname>Banizs</surname> <given-names>B</given-names></name><name><surname>Aydin-Son</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Michaud</surname> <given-names>EJ</given-names></name><name><surname>Yoder</surname> <given-names>BK</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function</article-title><source>PLOS Genetics</source><volume>1</volume><elocation-id>e53</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0010053</pub-id><pub-id pub-id-type="pmid">16254602</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Subramanian</surname> <given-names>R</given-names></name><name><surname>Bangs</surname> <given-names>F</given-names></name><name><surname>Omelchenko</surname> <given-names>T</given-names></name><name><surname>Liem</surname> <given-names>KF</given-names></name><name><surname>Kapoor</surname> <given-names>TM</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The kinesin-4 protein Kif7 regulates mammalian hedgehog signalling by organizing the cilium tip compartment</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>663</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1038/ncb2988</pub-id><pub-id pub-id-type="pmid">24952464</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname> <given-names>D</given-names></name><name><surname>Javadi Esfehani</surname> <given-names>Y</given-names></name><name><surname>Das</surname> <given-names>A</given-names></name><name><surname>Tsang</surname> <given-names>WY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1(Vpr)(BP)</article-title><source>EMBO Reports</source><volume>18</volume><elocation-id>e201642377</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201642377</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huangfu</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>A</given-names></name><name><surname>Rakeman</surname> <given-names>AS</given-names></name><name><surname>Murcia</surname> <given-names>NS</given-names></name><name><surname>Niswander</surname> <given-names>L</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hedgehog signalling in the mouse requires intraflagellar transport proteins</article-title><source>Nature</source><volume>426</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1038/nature02061</pub-id><pub-id pub-id-type="pmid">14603322</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname> <given-names>CC</given-names></name><name><surname>Angers</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Gli proteins in development and disease</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>27</volume><fpage>513</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154048</pub-id><pub-id pub-id-type="pmid">21801010</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>SH</given-names></name><name><surname>White</surname> <given-names>KA</given-names></name><name><surname>Somatilaka</surname> <given-names>BN</given-names></name><name><surname>Shelton</surname> <given-names>JM</given-names></name><name><surname>Richardson</surname> <given-names>JA</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The G protein-coupled receptor Gpr161 regulates forelimb formation, limb patterning and skeletal morphogenesis in a primary cilium-dependent manner</article-title><source>Development</source><volume>145</volume><elocation-id>dev154054</elocation-id><pub-id pub-id-type="doi">10.1242/dev.154054</pub-id><pub-id pub-id-type="pmid">29222391</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingham</surname> <given-names>PW</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Hedgehog signaling in animal development: paradigms and principles</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>3059</fpage><lpage>3087</lpage><pub-id pub-id-type="doi">10.1101/gad.938601</pub-id><pub-id pub-id-type="pmid">11731473</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoko</surname> <given-names>A</given-names></name><name><surname>Matsuyama</surname> <given-names>M</given-names></name><name><surname>Goto</surname> <given-names>H</given-names></name><name><surname>Ohmuro-Matsuyama</surname> <given-names>Y</given-names></name><name><surname>Hayashi</surname> <given-names>Y</given-names></name><name><surname>Enomoto</surname> <given-names>M</given-names></name><name><surname>Ibi</surname> <given-names>M</given-names></name><name><surname>Urano</surname> <given-names>T</given-names></name><name><surname>Yonemura</surname> <given-names>S</given-names></name><name><surname>Kiyono</surname> <given-names>T</given-names></name><name><surname>Izawa</surname> <given-names>I</given-names></name><name><surname>Inagaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cells</article-title><source>The Journal of Cell Biology</source><volume>197</volume><fpage>391</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1083/jcb.201106101</pub-id><pub-id pub-id-type="pmid">22529102</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname> <given-names>H</given-names></name><name><surname>Marshall</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ciliogenesis: building the cell's antenna</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>12</volume><fpage>222</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1038/nrm3085</pub-id><pub-id pub-id-type="pmid">21427764</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keeling</surname> <given-names>J</given-names></name><name><surname>Tsiokas</surname> <given-names>L</given-names></name><name><surname>Maskey</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cellular mechanisms of ciliary length control</article-title><source>Cells</source><volume>5</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3390/cells5010006</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Beachy</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Gli2 trafficking links Hedgehog-dependent activation of smoothened in the primary cilium to transcriptional activation in the nucleus</article-title><source>PNAS</source><volume>106</volume><fpage>21666</fpage><lpage>21671</lpage><pub-id pub-id-type="doi">10.1073/pnas.0912180106</pub-id><pub-id pub-id-type="pmid">19996169</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Jo</surname> <given-names>H</given-names></name><name><surname>Hong</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>MH</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name><name><surname>Lee</surname> <given-names>JK</given-names></name><name><surname>Heo</surname> <given-names>WD</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6781</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7781</pub-id><pub-id pub-id-type="pmid">25849865</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>Choi</surname> <given-names>JH</given-names></name><name><surname>Ringstad</surname> <given-names>N</given-names></name><name><surname>Dynlacht</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8087</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9087</pub-id><pub-id pub-id-type="pmid">26290419</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>T</given-names></name><name><surname>Tsang</surname> <given-names>WY</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Lane</surname> <given-names>W</given-names></name><name><surname>Dynlacht</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Centriolar kinesin Kif24 interacts with CP110 to remodel microtubules and regulate ciliogenesis</article-title><source>Cell</source><volume>145</volume><fpage>914</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.04.028</pub-id><pub-id pub-id-type="pmid">21620453</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liem</surname> <given-names>KF</given-names></name><name><surname>Ashe</surname> <given-names>A</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Satir</surname> <given-names>P</given-names></name><name><surname>Moran</surname> <given-names>J</given-names></name><name><surname>Beier</surname> <given-names>D</given-names></name><name><surname>Wicking</surname> <given-names>C</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The IFT-A complex regulates shh signaling through cilia structure and membrane protein trafficking</article-title><source>The Journal of Cell Biology</source><volume>197</volume><fpage>789</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1083/jcb.201110049</pub-id><pub-id pub-id-type="pmid">22689656</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Mains</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The <italic>C. elegans</italic> anaphase promoting complex and MBK-2/DYRK kinase act redundantly with CUL-3/MEL-26 ubiquitin ligase to degrade MEI-1 microtubule-severing activity after meiosis</article-title><source>Developmental Biology</source><volume>302</volume><fpage>438</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.09.053</pub-id><pub-id pub-id-type="pmid">17069791</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddika</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>409</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/ncb1848</pub-id><pub-id pub-id-type="pmid">19287380</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname> <given-names>A</given-names></name><name><surname>Pei</surname> <given-names>Z</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Fukuda</surname> <given-names>H</given-names></name><name><surname>Ono</surname> <given-names>Y</given-names></name><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Saito</surname> <given-names>I</given-names></name><name><surname>Kanegae</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery</article-title><source>Scientific Reports</source><volume>3</volume><elocation-id>1136</elocation-id><pub-id pub-id-type="doi">10.1038/srep01136</pub-id><pub-id pub-id-type="pmid">23355950</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mimoto</surname> <given-names>R</given-names></name><name><surname>Taira</surname> <given-names>N</given-names></name><name><surname>Takahashi</surname> <given-names>H</given-names></name><name><surname>Yamaguchi</surname> <given-names>T</given-names></name><name><surname>Okabe</surname> <given-names>M</given-names></name><name><surname>Uchida</surname> <given-names>K</given-names></name><name><surname>Miki</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DYRK2 controls the epithelial-mesenchymal transition in breast Cancer by degrading snail</article-title><source>Cancer Letters</source><volume>339</volume><fpage>214</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2013.06.005</pub-id><pub-id pub-id-type="pmid">23791882</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mimoto</surname> <given-names>R</given-names></name><name><surname>Nihira</surname> <given-names>NT</given-names></name><name><surname>Hirooka</surname> <given-names>S</given-names></name><name><surname>Takeyama</surname> <given-names>H</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Diminished DYRK2 sensitizes hormone receptor-positive breast Cancer to everolimus by the escape from degrading mTOR</article-title><source>Cancer Letters</source><volume>384</volume><fpage>27</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2016.10.015</pub-id><pub-id pub-id-type="pmid">27746162</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname> <given-names>R</given-names></name><name><surname>Freer</surname> <given-names>AM</given-names></name><name><surname>Zinyk</surname> <given-names>DL</given-names></name><name><surname>Crackower</surname> <given-names>MA</given-names></name><name><surname>Michaud</surname> <given-names>J</given-names></name><name><surname>Heng</surname> <given-names>HH</given-names></name><name><surname>Chik</surname> <given-names>KW</given-names></name><name><surname>Shi</surname> <given-names>XM</given-names></name><name><surname>Tsui</surname> <given-names>LC</given-names></name><name><surname>Cheng</surname> <given-names>SH</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name><name><surname>Hui</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development</article-title><source>Development</source><volume>124</volume><fpage>113</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">9006072</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname> <given-names>H</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Shin</surname> <given-names>JO</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>HK</given-names></name><name><surname>Eggenschwiller</surname> <given-names>JT</given-names></name><name><surname>Bok</surname> <given-names>J</given-names></name><name><surname>Ko</surname> <given-names>HW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intestinal cell kinase, a protein associated with endocrine-cerebro-osteodysplasia syndrome, is a key regulator of cilia length and hedgehog signaling</article-title><source>PNAS</source><volume>111</volume><fpage>8541</fpage><lpage>8546</lpage><pub-id pub-id-type="doi">10.1073/pnas.1323161111</pub-id><pub-id pub-id-type="pmid">24853502</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname> <given-names>K</given-names></name><name><surname>Katoh</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ciliary protein trafficking mediated by IFT and BBSome complexes with the aid of kinesin-2 and dynein-2 motors</article-title><source>The Journal of Biochemistry</source><volume>163</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1093/jb/mvx087</pub-id><pub-id pub-id-type="pmid">29272450</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niewiadomski</surname> <given-names>P</given-names></name><name><surname>Rohatgi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Measuring expression levels of endogenous gli genes by immunoblotting and Real-Time PCR</article-title><source>Methods in Molecular Biology</source><volume>1322</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2772-2_8</pub-id><pub-id pub-id-type="pmid">26179041</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname> <given-names>RX</given-names></name><name><surname>Ko</surname> <given-names>HW</given-names></name><name><surname>Huang</surname> <given-names>V</given-names></name><name><surname>Eun</surname> <given-names>CM</given-names></name><name><surname>Abler</surname> <given-names>LL</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Eggenschwiler</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tubby-like protein 3 (TULP3) regulates patterning in the mouse embryo through inhibition of hedgehog signaling</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>1740</fpage><lpage>1754</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp113</pub-id><pub-id pub-id-type="pmid">19286674</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocbina</surname> <given-names>PJ</given-names></name><name><surname>Eggenschwiler</surname> <given-names>JT</given-names></name><name><surname>Moskowitz</surname> <given-names>I</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Complex interactions between genes controlling trafficking in primary cilia</article-title><source>Nature Genetics</source><volume>43</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1038/ng.832</pub-id><pub-id pub-id-type="pmid">21552265</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocbina</surname> <given-names>PJ</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Intraflagellar Transport, cilia, and mammalian hedgehog signaling: analysis in mouse embryonic fibroblasts</article-title><source>Developmental Dynamics</source><volume>237</volume><fpage>2030</fpage><lpage>2038</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21551</pub-id><pub-id pub-id-type="pmid">18488998</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paige Taylor</surname> <given-names>S</given-names></name><name><surname>Kunova Bosakova</surname> <given-names>M</given-names></name><name><surname>Varecha</surname> <given-names>M</given-names></name><name><surname>Balek</surname> <given-names>L</given-names></name><name><surname>Barta</surname> <given-names>T</given-names></name><name><surname>Trantirek</surname> <given-names>L</given-names></name><name><surname>Jelinkova</surname> <given-names>I</given-names></name><name><surname>Duran</surname> <given-names>I</given-names></name><name><surname>Vesela</surname> <given-names>I</given-names></name><name><surname>Forlenza</surname> <given-names>KN</given-names></name><name><surname>Martin</surname> <given-names>JH</given-names></name><name><surname>Hampl</surname> <given-names>A</given-names></name><name><surname>Bamshad</surname> <given-names>M</given-names></name><name><surname>Nickerson</surname> <given-names>D</given-names></name><name><surname>Jaworski</surname> <given-names>ML</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Ko</surname> <given-names>HW</given-names></name><name><surname>Cohn</surname> <given-names>DH</given-names></name><name><surname>Krakow</surname> <given-names>D</given-names></name><name><surname>Krejci</surname> <given-names>P</given-names></name><collab>University of Washington Center for Mendelian Genomics</collab></person-group><year iso-8601-date="2016">2016</year><article-title>An inactivating mutation in intestinal cell kinase, <italic>ICK</italic>, impairs hedgehog signalling and causes short rib-polydactyly syndrome</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>3998</fpage><lpage>4011</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw240</pub-id><pub-id pub-id-type="pmid">27466187</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>KM</given-names></name><name><surname>Ishidate</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>K</given-names></name><name><surname>Shirayama</surname> <given-names>M</given-names></name><name><surname>Trzepacz</surname> <given-names>C</given-names></name><name><surname>Schubert</surname> <given-names>CM</given-names></name><name><surname>Priess</surname> <given-names>JR</given-names></name><name><surname>Mello</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The minibrain kinase homolog, mbk-2, is required for spindle positioning and asymmetric cell division in early <italic>C. elegans</italic> embryos</article-title><source>Developmental Biology</source><volume>265</volume><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2003.09.024</pub-id><pub-id pub-id-type="pmid">14697358</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellettieri</surname> <given-names>J</given-names></name><name><surname>Reinke</surname> <given-names>V</given-names></name><name><surname>Kim</surname> <given-names>SK</given-names></name><name><surname>Seydoux</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Coordinate activation of maternal protein degradation during the egg-to-embryo transition in <italic>C. elegans</italic></article-title><source>Developmental Cell</source><volume>5</volume><fpage>451</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(03)00231-4</pub-id><pub-id pub-id-type="pmid">12967564</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plotnikova</surname> <given-names>OV</given-names></name><name><surname>Seo</surname> <given-names>S</given-names></name><name><surname>Cottle</surname> <given-names>DL</given-names></name><name><surname>Conduit</surname> <given-names>S</given-names></name><name><surname>Hakim</surname> <given-names>S</given-names></name><name><surname>Dyson</surname> <given-names>JM</given-names></name><name><surname>Mitchell</surname> <given-names>CA</given-names></name><name><surname>Smyth</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>INPP5E interacts with AURKA, linking phosphoinositide signaling to primary cilium stability</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>364</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1242/jcs.161323</pub-id><pub-id pub-id-type="pmid">25395580</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugacheva</surname> <given-names>EN</given-names></name><name><surname>Jablonski</surname> <given-names>SA</given-names></name><name><surname>Hartman</surname> <given-names>TR</given-names></name><name><surname>Henske</surname> <given-names>EP</given-names></name><name><surname>Golemis</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>HEF1-dependent Aurora A activation induces disassembly of the primary cilium</article-title><source>Cell</source><volume>129</volume><fpage>1351</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.04.035</pub-id><pub-id pub-id-type="pmid">17604723</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname> <given-names>JF</given-names></name><name><surname>Blacque</surname> <given-names>OE</given-names></name><name><surname>Leroux</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The base of the cilium: roles for transition fibres and the transition zone in ciliary formation, maintenance and compartmentalization</article-title><source>EMBO Reports</source><volume>13</volume><fpage>608</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.73</pub-id><pub-id pub-id-type="pmid">22653444</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname> <given-names>JF</given-names></name><name><surname>Leroux</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genes and molecular pathways underpinning ciliopathies</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>533</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.60</pub-id><pub-id pub-id-type="pmid">28698599</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohatgi</surname> <given-names>R</given-names></name><name><surname>Milenkovic</surname> <given-names>L</given-names></name><name><surname>Scott</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Patched1 regulates hedgehog signaling at the primary cilium</article-title><source>Science</source><volume>317</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1126/science.1139740</pub-id><pub-id pub-id-type="pmid">17641202</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname> <given-names>WC</given-names></name><name><surname>Rosen</surname> <given-names>B</given-names></name><name><surname>West</surname> <given-names>AP</given-names></name><name><surname>Koutsourakis</surname> <given-names>M</given-names></name><name><surname>Bushell</surname> <given-names>W</given-names></name><name><surname>Iyer</surname> <given-names>V</given-names></name><name><surname>Mujica</surname> <given-names>AO</given-names></name><name><surname>Thomas</surname> <given-names>M</given-names></name><name><surname>Harrow</surname> <given-names>J</given-names></name><name><surname>Cox</surname> <given-names>T</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Biggs</surname> <given-names>P</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Nefedov</surname> <given-names>M</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id><pub-id pub-id-type="pmid">21677750</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snouffer</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Walsh</surname> <given-names>J</given-names></name><name><surname>Lupu</surname> <given-names>F</given-names></name><name><surname>Norman</surname> <given-names>R</given-names></name><name><surname>Lechtreck</surname> <given-names>K</given-names></name><name><surname>Ko</surname> <given-names>HW</given-names></name><name><surname>Eggenschwiler</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cell Cycle-Related kinase (CCRK) regulates ciliogenesis and hedgehog signaling in mice</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006912</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006912</pub-id><pub-id pub-id-type="pmid">28817564</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svärd</surname> <given-names>J</given-names></name><name><surname>Heby-Henricson</surname> <given-names>K</given-names></name><name><surname>Henricson</surname> <given-names>KH</given-names></name><name><surname>Persson-Lek</surname> <given-names>M</given-names></name><name><surname>Rozell</surname> <given-names>B</given-names></name><name><surname>Lauth</surname> <given-names>M</given-names></name><name><surname>Bergström</surname> <given-names>A</given-names></name><name><surname>Ericson</surname> <given-names>J</given-names></name><name><surname>Toftgård</surname> <given-names>R</given-names></name><name><surname>Teglund</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway</article-title><source>Developmental Cell</source><volume>10</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.12.013</pub-id><pub-id pub-id-type="pmid">16459298</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taira</surname> <given-names>N</given-names></name><name><surname>Nihira</surname> <given-names>K</given-names></name><name><surname>Yamaguchi</surname> <given-names>T</given-names></name><name><surname>Miki</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage</article-title><source>Molecular Cell</source><volume>25</volume><fpage>725</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.02.007</pub-id><pub-id pub-id-type="pmid">17349958</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taira</surname> <given-names>N</given-names></name><name><surname>Yamamoto</surname> <given-names>H</given-names></name><name><surname>Yamaguchi</surname> <given-names>T</given-names></name><name><surname>Miki</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>4909</fpage><lpage>4919</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.042341</pub-id><pub-id pub-id-type="pmid">19965871</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taira</surname> <given-names>N</given-names></name><name><surname>Mimoto</surname> <given-names>R</given-names></name><name><surname>Kurata</surname> <given-names>M</given-names></name><name><surname>Yamaguchi</surname> <given-names>T</given-names></name><name><surname>Kitagawa</surname> <given-names>M</given-names></name><name><surname>Miki</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human Cancer cells</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>859</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1172/JCI60818</pub-id><pub-id pub-id-type="pmid">22307329</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname> <given-names>LW</given-names></name><name><surname>Ranum</surname> <given-names>PT</given-names></name><name><surname>Lefebvre</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CDKL5 regulates flagellar length and localizes to the base of the flagella in <italic>Chlamydomonas</italic></article-title><source>Molecular Biology of the Cell</source><volume>24</volume><fpage>588</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1091/mbc.e12-10-0718</pub-id><pub-id pub-id-type="pmid">23283985</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukachinsky</surname> <given-names>H</given-names></name><name><surname>Lopez</surname> <given-names>LV</given-names></name><name><surname>Salic</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A mechanism for vertebrate hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes</article-title><source>The Journal of Cell Biology</source><volume>191</volume><fpage>415</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1083/jcb.201004108</pub-id><pub-id pub-id-type="pmid">20956384</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varjosalo</surname> <given-names>M</given-names></name><name><surname>Björklund</surname> <given-names>M</given-names></name><name><surname>Cheng</surname> <given-names>F</given-names></name><name><surname>Syvänen</surname> <given-names>H</given-names></name><name><surname>Kivioja</surname> <given-names>T</given-names></name><name><surname>Kilpinen</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Kallioniemi</surname> <given-names>O</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>He</surname> <given-names>WW</given-names></name><name><surname>Ojala</surname> <given-names>P</given-names></name><name><surname>Taipale</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling</article-title><source>Cell</source><volume>133</volume><fpage>537</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.02.047</pub-id><pub-id pub-id-type="pmid">18455992</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Zhuo</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>1355</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1242/jcs.114918</pub-id><pub-id pub-id-type="pmid">23345402</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Kirschner</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The master cell cycle regulator APC-Cdc20 regulates ciliary length and disassembly of the primary cilium</article-title><source>eLife</source><volume>3</volume><elocation-id>e03083</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03083</pub-id><pub-id pub-id-type="pmid">25139956</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wemmer</surname> <given-names>KA</given-names></name><name><surname>Marshall</surname> <given-names>WF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Flagellar length control in Chlamydomonas--paradigm for organelle size regulation</article-title><source>International Review of Cytology</source><volume>260</volume><fpage>175</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/S0074-7696(06)60004-1</pub-id><pub-id pub-id-type="pmid">17482906</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Lai</surname> <given-names>CK</given-names></name><name><surname>Evangelista</surname> <given-names>M</given-names></name><name><surname>Hongo</surname> <given-names>JA</given-names></name><name><surname>de Sauvage</surname> <given-names>FJ</given-names></name><name><surname>Scales</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>1910</fpage><lpage>1922</lpage><pub-id pub-id-type="doi">10.1128/MCB.01089-09</pub-id><pub-id pub-id-type="pmid">20154143</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>NF</given-names></name><name><surname>Iyer</surname> <given-names>JK</given-names></name><name><surname>Buchheim</surname> <given-names>JA</given-names></name><name><surname>Meek</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulation of flagellar length in Chlamydomonas</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>19</volume><fpage>494</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2008.07.005</pub-id><pub-id pub-id-type="pmid">18692148</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama-Mashima</surname> <given-names>S</given-names></name><name><surname>Yogosawa</surname> <given-names>S</given-names></name><name><surname>Kanegae</surname> <given-names>Y</given-names></name><name><surname>Hirooka</surname> <given-names>S</given-names></name><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Horiuchi</surname> <given-names>T</given-names></name><name><surname>Ohashi</surname> <given-names>T</given-names></name><name><surname>Yanaga</surname> <given-names>K</given-names></name><name><surname>Saruta</surname> <given-names>M</given-names></name><name><surname>Oikawa</surname> <given-names>T</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver Cancer</article-title><source>Cancer Letters</source><volume>451</volume><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2019.02.046</pub-id><pub-id pub-id-type="pmid">30851422</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiple functions of DYRK2 in Cancer and tissue development</article-title><source>FEBS Letters</source><volume>593</volume><fpage>2953</fpage><lpage>2965</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.13601</pub-id><pub-id pub-id-type="pmid">31505048</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Diener</surname> <given-names>DR</given-names></name><name><surname>Choma</surname> <given-names>MA</given-names></name><name><surname>Rosenbaum</surname> <given-names>JL</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Target-of-rapamycin complex 1 (Torc1) signaling modulates cilia size and function through protein synthesis regulation</article-title><source>PNAS</source><volume>109</volume><fpage>2021</fpage><lpage>2026</lpage><pub-id pub-id-type="doi">10.1073/pnas.1112834109</pub-id><pub-id pub-id-type="pmid">22308353</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57381.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Pedersen</surname><given-names>Lotte</given-names></name><role>Reviewing Editor</role><aff><institution>University of Copenhagen</institution><country>Denmark</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>Thank you for submitting your article &quot;The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Piali Sengupta as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>Yoshida et al. characterize the phenotype of <italic>Dyrk2</italic> mutant mice, and show that loss of this kinase results in reduced Hh signaling both in vivo and in cells derived from the <italic>Dyrk2<sup>-/-</sup></italic> embryos. They also show that <italic>Dyrk2<sup>-/-</sup></italic> embryos and MEFs have ciliary defects- primarily longer cilia with abnormal tips, and defects in the trafficking of Hh components <italic>Gli2</italic> and <italic>Gli3</italic>. <italic>Dyrk2</italic> is postulated to localize to transition zone of cilia and regulate transcription of AurA, which the authors propose as the mechanism underlying ciliary length changes.</p><p>The data presented are robust and thorough. The authors are recognized leaders in understanding the role of <italic>Dyrk2</italic> in cancer pathways and in DNA damage response through phosphorylation of diverse substrates including p53 and c-Jun/Myc. They now highlight a completely novel role of this kinase in embryonic development as a regulator of ciliary morphology and Hh signaling. <italic>Dyrk2</italic> has also been postulated to act as scaffold for EDVP complex in proteolysis of substrates such as the centrosome protein CP110 and microtubule severing enzyme, Katanin. The authors now convincingly show a role of <italic>Dyrk2</italic> as a positive regulator of Hh pathway by careful knockout studies during mouse embryogenesis in the context of craniofacial and skeletal development and Hh signaling assays in vitro. These results are in stark contrast to a previously published paper using <italic>Dyrk2</italic> overexpression that proposed a negative regulatory role of <italic>Dyrk2</italic> in Hh pathway through <italic>Gli2</italic> and Gli3 degradation and direct phosphorylation of <italic>Gli2</italic> at two residues (S385, S1011) (PMID: 18455992). Despite the nicely demonstrated broad role of this kinase in Hh signaling and late embryogenesis, the mechanism proposed for this postulated transition zone-localized protein in causing ciliary dysmorphology through AurA kinase transcription is unclear. Therefore, this work presents interesting findings and is generally well-performed and merits publication, though there are some additional experiments and/or questions to address that could improve the work considerably.</p><p>Essential revisions:</p><p>1) The authors show low Hh signaling by ISH/qRT PCR of Hh pathway targets in craniofacial region and limbs at e13.5. The later skeletal abnormalities are consistent with Hh signaling defects (although no polydactyly is seen). However, no neural tube patterning defects are seen. Considering that cilia length abnormalities are seen at E10.5 (earlier stages have not been looked at), and <italic>Gli2/3/</italic>SuFu are accumulated in MEF cilia irrespective of <italic>Smo</italic> activation, it is surprising that the Hh signaling defects are not observed in earlier stages of development. The neural tube development defects are shown to be unaffected only at the branchial level at E10.5. The authors should at least test total RNA levels of Hh pathway targets in early stage embryos and rule out dorsoventral patterning defects at earlier stages.</p><p>2) The phenotypes of the <italic>Dyrk2<sup>-/-</sup></italic> mice as described seem to be fairly limited to bone growth and differentiation (and also neural crest-derived craniofacial structures). This certainly points to a role for Hh signaling, but could indicate that the phenotype is tissue specific. Is <italic>Dyrk2</italic> expression tissue restricted? If so this would be very interesting since it would point to <italic>Dyrk2</italic> being a tissue-specific regulator of cilia. Few proteins that regulate cilia in a cell type-specific manner have been identified and little is known about how such regulation is achieved. Making this link might increase the impact of the paper, if it is the case.</p><p>3) The localization of <italic>Dyrk2</italic> in transition zone and/or centrosome should be better documented using transition zone markers and necessary controls for the antibody using ko MEFs.</p><p>4) The accumulation of <italic>Gli2</italic>/<italic>3</italic> in resting MEF cilia (but not of <italic>Smo</italic>) is similar to PKA null MEFs (PMID: 22007132), which in contrast show high Hh signaling. Here, an alternative hypothesis regarding <italic>Dyrk2</italic> function such as its role in affecting turnaround in ciliary tips and/or affecting axonemal architecture through its function as a kinase for <italic>Gli2</italic> and/or EDVP complex scaffold, respectively might be considered.</p><p>5) A more thorough characterization of the ciliary defects in the <italic>Dyrk2<sup>-/-</sup></italic> cells is desirable. Primarily, what happens to cilia frequency in <italic>Dyrk2<sup>-/-</sup></italic> cells? If cilia frequency is not affected in these mutants, this would not detract from the work or the conclusions of the paper, but it is important to know the answer. They should also assess whether cilia frequency in cycling <italic>Dyrk2<sup>-/-</sup></italic> MEFs is different- it seems possible loss of this kinase might increase cilia frequency when few cilia are typically present, especially given that they find that <italic>AurkA</italic> expression is reduced in the mutant cells. Again, it would just be interesting to know this either way.</p><p>6) The potential mechanism by which DYRK2 regulates ciliary length is insufficiently discussed/addressed in this study. First of all, the Introduction needs to provide a more thorough and accurate description of the literature relevant for ciliary length control and disassembly, as well as a clear description of what the differences are between steady state ciliary length control and ciliary disassembly observed e.g. during serum re-addition to starved cultures of mammalian cells. Second, the authors suggest that one potential mechanism by which DYRK2 negatively regulates ciliary length is by controlling expression of key cilia disassembly factors such as AURKA, but it is unclear why a transcriptomics approach was used in the first place. Moreover, the observed changes in the transcriptome could be a consequence rather than a cause of the long cilia phenotype seen in DYRK2 deficient cells. Therefore, a rescue experiment that shows normal ciliary length of DYRK2 mutant cells when AURKA expression is normalized must be provided if the authors want to claim that altered AURKA levels are responsible for the phenotype. DYRK2 is a kinase that the authors show is concentrated near the ciliary base; previous work implicated the EDVP complex in regulation of katanin (PMID: 19287380) and CP110 proteolysis (PMID: 28242748). CP110 is a key regulator of ciliogenesis also implicated in ciliary length control, thus an obvious question to ask is what happens to CP110 (centrosomal) levels in cells lacking DYRK2. This experiment should be fairly easy to do as good antibodies against CP110 are commercially available. Katanin levels could be analysed similarly.</p><p>7) Subsection “<italic>Dyrk2</italic> deficiency cause suppression of Hedgehog signaling during mouse embryogenesis” and Figure 1: Some quantitative analysis is missing here. How many embryos/animals were examined?</p><p>8) Figure 3D: What is the relative expression levels of the wild type and mutant DYRK2 protein in these experiments and are the transfection efficiencies similar for both constructs? This is important to know in order to rule out that the observed difference in rescue effect of the two constructs is not simply due to different cellular expression level. Also, kinase-dead <italic>Dyrk2</italic> does restore significant levels of <italic>Ptch1</italic> transcript with respect to wild-type. Statistical significance for <italic>Gli1</italic> levels is not mentioned with respect to wild-type. <italic>Dyrk2</italic> could have kinase-independent functions as a scaffold.</p><p>9) Subsection “DYRK2 regulates ciliogenesis” and Figure 5—figure supplement 3: without quantification the data is not very meaningful, so either the data needs to be quantified or alternatively removed.</p><p>10) The manuscript contains several grammatical errors and typos that need to be corrected to enhance readability and clarity.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57381.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>Essential revisions:</p><disp-quote content-type="editor-comment"><p>1) The authors show low Hh signaling by ISH/qRT PCR of Hh pathway targets in craniofacial region and limbs at e13.5. The later skeletal abnormalities are consistent with Hh signaling defects (although no polydactyly is seen). However, no neural tube patterning defects are seen. Considering that cilia length abnormalities are seen at E10.5 (earlier stages have not been looked at), and <italic>Gli2/3/</italic>SuFu are accumulated in MEF cilia irrespective of <italic>Smo</italic> activation, it is surprising that the Hh signaling defects are not observed in earlier stages of development. The neural tube development defects are shown to be unaffected only at the branchial level at E10.5. The authors should at least test total RNA levels of Hh pathway targets in early stage embryos and rule out dorsoventral patterning defects at earlier stages.</p></disp-quote><p>As requested, we performed qPCR of Hh target genes using cDNA from whole embryo at E9.5. The results demonstrated a repression of <italic>Gli1</italic> (p=0.077), <italic>Ptch1</italic> (p&lt;0.01), and <italic>Foxf2</italic> (p&lt;0.01) in <italic>Dyrk2<sup>-/-</sup></italic> embryos newly prepared Figure 2—figure supplement 1B. These data clearly show the defect in Hh signaling in <italic>Dyrk2<sup>-/-</sup> </italic>mice at early stage embryos (E9.5).</p><p>To further confirm this finding, we performed in situ hybridization for <italic>Ptch1</italic> at E10.5 newly prepared Figure 2—figure supplement 1C. The results demonstrated that <italic>Ptch1</italic>-expression was decreased in several regions such as the mandibular arch in <italic>Dyrk2<sup>-/-</sup></italic> embryos, but remained unchanged in the neural tube. Based on these data, we concluded that Hh signaling is active state at the neural tube in <italic>Dyrk2<sup>-/-</sup></italic> embryos.</p><p>Additionally, we speculate that these data have relation to a spatiotemporal expression-pattern of <italic>Dyrk2</italic> in embryo we also commented below (Essential revisions comment 2).</p><p>According to the reviewer’s comment, we added newly prepared Figure 2—figure supplement 1B and Figure 2—figure supplement 1C, and their figure legends.</p><p>In addition, we added Figure 2—figure supplement 1—source data 1.</p><p>We also revised the following sentences in the revised text:</p><p>Results: subsection “<italic>Dyrk2</italic> deficiency cause suppression of Hedgehog signaling during mouse embryogenesis”, third paragraph.</p><p>Materials and methods: subsection “In situ hybridization” and subsection “Quantitative real-time polymerase chain reaction (qPCR)”.</p><p>Table 2: We added information of a primer set for <italic>Ptch1</italic>-probe.</p><disp-quote content-type="editor-comment"><p>2) The phenotypes of the <italic>Dyrk2<sup>-/-</sup></italic> mice as described seem to be fairly limited to bone growth and differentiation (and also neural crest-derived craniofacial structures). This certainly points to a role for Hh signaling, but could indicate that the phenotype is tissue specific. Is <italic>Dyrk2</italic> expression tissue restricted? If so this would be very interesting since it would point to <italic>Dyrk2</italic> being a tissue-specific regulator of cilia. Few proteins that regulate cilia in a cell type-specific manner have been identified and little is known about how such regulation is achieved. Making this link might increase the impact of the paper, if it is the case.</p></disp-quote><p>We appreciate your important suggestion and really agree with your comment.</p><p>We have tried to identify the localization of DYRK2 using wild-type and <italic>Dyrk2<sup>-/-</sup></italic> embryos by immunohistochemistry and in situ hybridization. Indeed, we have performed the immunohistochemistry using almost all commercially available antibodies against DYRK2 (more than 15 antibodies). In addition, we have tried to develop original antibodies using two independent epitopes.</p><p>Although we have also verified various conditions (e.g. fixation- and antigen retrieved-conditions using cryo-, frozen-, and paraffin-sections), we could not successfully detect specific immuno-positive signals (i.e. detecting only wild-type but not <italic>Dyrk2<sup>-/-</sup></italic> embryos). We have also performed in situ hybridization using several probes for <italic>Dyrk2</italic>; however, we could not obtain positive results.</p><p>We would thus argue that, in the future, we would like to try to show it in a separate study.</p><disp-quote content-type="editor-comment"><p>3) The localization of <italic>Dyrk2</italic> in transition zone and/or centrosome should be better documented using transition zone markers and necessary controls for the antibody using ko MEFs.</p></disp-quote><p>As suggested, we performed immunocytostaining for a TZ marker, NPHP1, in hTERT-RPE1 cells transfected with DYRK2-Halo vector. The results demonstrated that DYRK2-Halo-tag-positive signals are co-localized in NPHP1-positive signals newly prepared Figure 5D.</p><p>We analyzed the cellular localization of DYRK2 using hTERT-RPE1 cells overexpressed DYRK2-Halo vector, because we could not find available anti-DYRK2 antibodies to detect endogenous DYRK2 by immunocytostaining. Therefore, we performed a control experiment for anti-Halo tag and DYRK2 antibody in hTERT-RPE1 cells transfected with “empty vector (pFN22K-Halo Tag-CMVd1-Flexi-vector)”. The results indicated that no signal was observed newly prepared Figure 5C.</p><p>Accordingly, we added newly prepared Figure 5C and D and their figure legends.</p><p>We also added the following sentences in the revised text: “No signal for anti-HaloTag (Figure 5C) or anti-DYRK2 (data not shown) was observed in hTERT-RPE1 cells transfected with empty vector (pFN22K-Halo Tag-CMVd1-Flexi-vector). Moreover, immuno-positive signals for DYRK2-HaloTag were co-localized with a TZ marker, NPHP1 (Figure 5D)”.</p><p>We added information of anti-NPHP1 antibody and pFN22K-Halo Tag-CMVd1-Flexi-vector (empty vector) in Key Resources Table.</p><disp-quote content-type="editor-comment"><p>4) The accumulation of <italic>Gli2/3</italic> in resting MEF cilia (but not of <italic>Smo</italic>) is similar to PKA null MEFs (PMID: 22007132), which in contrast show high Hh signaling. Here, an alternative hypothesis regarding <italic>Dyrk2</italic> function such as its role in affecting turnaround in ciliary tips and/or affecting axonemal architecture through its function as a kinase for <italic>Gli2</italic> and/or EDVP complex scaffold, respectively might be considered.</p></disp-quote><p>Thank you for your important suggestion. As our response to Essential revisions comment 6, to identify DYRK2’s substrate involving in ciliogenesis, we have analyzed protein levels of CP110 and KATANIN p60, which are postulated as DYRK2’s substrates, in <italic>Dyrk2<sup>-/-</sup> </italic>MEFs. The results showed no obvious difference between wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs in these proteins newly prepared Figure 6—figure supplement 4.</p><p>While we are now trying to identify novel substrates of DYRK2 for ciliogenesis, we need more time to accomplish. In this context, we would like to show it in a separate study regarding the identification of novel substrates of DYRK2 involving in ciliogenesis.</p><p>Accordingly, we added newly prepared Figure 6—figure supplement 4 and its figure legend.</p><p>We also added the following sentence in the revised text: “Moreover, a centrosome protein CP110 ,(Maddika and Chen 2009) and a microtubule severing enzyme, KATANIN p60 et al.,(Hossain 2017), have been identified as substrates of DYRK2 for proteolysis. In <italic>Dyrk2<sup>-/-</sup></italic> MEFs, however, no obvious difference in protein levels of both CP110 and KATANIN p60 was observed (Figure 6—figure supplement 4)”.</p><p>We added information of anti-CP110 and KATANIN p60 antibodies in Key Resources Table.</p><disp-quote content-type="editor-comment"><p>5) A more thorough characterization of the ciliary defects in the <italic>Dyrk2<sup>-/-</sup></italic> cells is desirable. Primarily, what happens to cilia frequency in <italic>Dyrk2</italic><sup><italic>-/</italic>-</sup> cells? If cilia frequency is not affected in these mutants, this would not detract from the work or the conclusions of the paper, but it is important to know the answer. They should also assess whether cilia frequency in cycling <italic>Dyrk2<sup>-/-</sup></italic> MEFs is different- it seems possible loss of this kinase might increase cilia frequency when few cilia are typically present, especially given that they find that <italic>AurkA</italic> expression is reduced in the mutant cells. Again, it would just be interesting to know this either way.</p></disp-quote><p>According to the reviewer’s comment, we measured the proportion of ciliated cells newly prepared Figure 4—figure supplement 3A-B, and confirmed no difference between wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs.</p><p>We also analyzed the proportion of ciliated cells in cell cycling wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs using KI67-staining newly prepared Figure 4—figure supplement 3C. The results showed that both wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs in KI67-positive cells were hardly ciliated.</p><p>We also added the following sentences in the revised text: “In contrast to the length and morphology of primary cilia, no difference was observed on the proportion of ciliated cells in wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs (Figure 4—figure supplement 3A-B). Similarly, in cell-cycling (KI67-positive) wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs, there was comparable in the proportion of ciliated cells (ciliated cells in KI67-positive cells is 1 per 199 and 1 per 139 cells in wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs, respectively) (Figure 4—figure supplement 3C)”.</p><p>We added Figure 4—figure supplement 3—source data 1, and information of anti-KI67 and ARL13B (abcam) antibodies in Key Resources Table.</p><disp-quote content-type="editor-comment"><p>6) The potential mechanism by which DYRK2 regulates ciliary length is insufficiently discussed/addressed in this study. First of all, the Introduction needs to provide a more thorough and accurate description of the literature relevant for ciliary length control and disassembly, as well as a clear description of what the differences are between steady state ciliary length control and ciliary disassembly observed e.g. during serum re-addition to starved cultures of mammalian cells.</p></disp-quote><p>As indicated, we revised the third paragraph of the Introduction.</p><disp-quote content-type="editor-comment"><p>Second, the authors suggest that one potential mechanism by which DYRK2 negatively regulates ciliary length is by controlling expression of key cilia disassembly factors such as AURKA, but it is unclear why a transcriptomics approach was used in the first place. Moreover, the observed changes in the transcriptome could be a consequence rather than a cause of the long cilia phenotype seen in DYRK2 deficient cells. Therefore, a rescue experiment that shows normal ciliary length of DYRK2 mutant cells when AURKA expression is normalized must be provided if the authors want to claim that altered AURKA levels are responsible for the phenotype. DYRK2 is a kinase that the authors show is concentrated near the ciliary base; previous work implicated the EDVP complex in regulation of katanin (PMID: 19287380) and CP110 proteolysis (PMID: 28242748). CP110 is a key regulator of ciliogenesis also implicated in ciliary length control, thus an obvious question to ask is what happens to CP110 (centrosomal) levels in cells lacking DYRK2. This experiment should be fairly easy to do as good antibodies against CP110 are commercially available. Katanin levels could be analysed similarly.</p></disp-quote><p>First of all, we have also focused on and analyzed protein levels of CP110 and KATANIN p60, which are postulated as DYRK2’s substrates. Immuno-blotting of CP110 and KATANIN p60, however, showed no obvious difference between wild-type and <italic>Dyrk2<sup>-/-</sup> </italic>MEFs newly prepared Figure 6—figure supplement 4.</p><p>Therefore, to understand the phenotype of <italic>Dyrk2<sup>-/-</sup></italic> cells in ciliogenesis in more detail and find novel clues, we performed transcriptome analysis.</p><p>Second, we performed a rescue experiment by over-expression of AURKA-EGFP in <italic>Dyrk2<sup>-/-</sup> </italic>MEFs newly prepared Figure 9. We observed a reduction of the cilia length in AURKA-EGFP-transfected <italic>Dyrk2<sup>-/-</sup></italic> MEFs, but not in EGFP-transfected <italic>Dyrk2<sup>-/-</sup></italic> MEFs. These data support that downregulated <italic>Aurka-</italic>expression is, at least in part, associated with phenotypes of <italic>Dyrk2<sup>-/</sup></italic><sup>-</sup> cells.</p><p>Accordingly, we revised following points,</p><p>Related to CP110 and KATANIN p60:</p><p>We added newly prepared Figure 6—figure supplement 4 and its figure legend.</p><p>We also revised the text subsection “Deletion of DYRK2 induces abnormal ciliary trafficking of Hedgehog pathway components”, last paragraph.</p><p>We added information of anti-CP110 and KATANIN p60 antibody in Key Resources Table.</p><p>Related to a rescue experiment of AURKA:</p><p>We added new data newly prepared Figure 9 and its figure legend.</p><p>In addition, we added Figure 9—source data 1.</p><p>We also revised the following sentences in the revised text:</p><p>Results: subsection “Deletion of <italic>Dyrk2</italic> dysregulates the expression of <italic>Aurka</italic> and other cilia-disassembly genes”, end of first paragraph.</p><p>Materials and methods: subsection “Plasmid constructs”, subsection “Cell culture and transfection”, and subsection “Immunocytochemistry”.</p><p>Table 2: We added information of a primer set for mouse <italic>Aurka</italic> CDS.</p><p>We added information of expression vector (mouse <italic>Aurka</italic>/pEGFP-C1 and pEGFP-C1) anti-GFP antibodies in Key Resources Table.</p><disp-quote content-type="editor-comment"><p>7) Subsection “<italic>Dyrk2</italic> deficiency cause suppression of Hedgehog signaling during mouse embryogenesis” and Figure 1: Some quantitative analysis is missing here. How many embryos/animals were examined?</p></disp-quote><p>According to the reviewer’s comment, we added the sentence: “Ten embryos of each wild-type and <italic>Dyrk2<sup>-/-</sup></italic> mice were analyzed”.</p><disp-quote content-type="editor-comment"><p>8) Figure 3D: What is the relative expression levels of the wild type and mutant DYRK2 protein in these experiments and are the transfection efficiencies similar for both constructs? This is important to know in order to rule out that the observed difference in rescue effect of the two constructs is not simply due to different cellular expression level.</p></disp-quote><p>We added the immune-blotting data showing over-expression protein levels newly prepared Figure 3—figure supplement 1D and its figure legend, and confirmed that both WT and <italic>K251R</italic> were expressed with equal levels.</p><p>Additionally, to describe a method for determination of MOI, we added the following sentence “MOI for MEFs was determined using an adenovirus construct for GFP-expression” in the revised text, and information of an adenovirus for GFP-expression in Key Resources Table.</p><disp-quote content-type="editor-comment"><p>Also, kinase-dead <italic>Dyrk2</italic> does restore significant levels of <italic>Ptch1</italic> transcript with respect to wild-type. Statistical significance for <italic>Gli1</italic> levels is not mentioned with respect to wild-type. <italic>Dyrk2</italic> could have kinase-independent functions as a scaffold.</p></disp-quote><p>First, we added the <italic>P</italic>-value “p=0.254” in Figure 3D. As pointed out, kinase-dead DYRK2 (<italic>K251R</italic>) showed a moderate effect for expression of <italic>Gli1</italic> and <italic>Ptch1</italic>. We consider that these data show a kinase independent function of DYRK2 (e.g. as scaffold protein, as the reviewers pointed out). Therefore, we added the following sentences “Additionally, over-expression of the <italic>K251R</italic> construct slightly increased <italic>Gli1</italic> and <italic>Ptch1</italic> expression in comparison with that of empty vector (Figure 3D). This kinase-independent effect might be associated with a function of DYRK2 as a scaffold protein Maddika and Chen, 2009”.</p><disp-quote content-type="editor-comment"><p>9) Subsection “DYRK2 regulates ciliogenesis” and Figure 5—figure supplement 3: without quantification the data is not very meaningful, so either the data needs to be quantified or alternatively removed.</p></disp-quote><p>According to the reviewer’s comment, we removed the data Original Figure 5—figure supplement 3: Stability of primary cilia in <italic>Dyrk2<sup>-/-</sup> </italic>MEFs. Accordingly, we deleted the following sentences from the revised text: “Although we confirmed the acetylated and glutamylated tubulin modifications in the axoneme that are associated with stability of microtubules ,(Janke and Bulinski 2011), both modifications remained unchanged in <italic>Dyrk2<sup>-/-</sup> </italic>MEFs cilia according to immunostaining. Additionally, destabilization of axonemal microtubules induced by exposure to 4 °C et al.,(He 2014) showed no difference in loss of acetylated tubulin modification compared to that observed in wild-type”.</p><p>We also deleted an information of anti-Glutamylated tubulin antibody from Key Resources Table.</p><disp-quote content-type="editor-comment"><p>10) The manuscript contains several grammatical errors and typos that need to be corrected to enhance readability and clarity.</p></disp-quote><p>As requested, we carefully checked grammatical errors and typos throughout the revised manuscript and appropriately revised.</p></body></sub-article></article>